CELLETS® 700

(700-1000 µm)

CELLETS® 700 is a subtype of pellets made of microcrystalline cellulose. The size ranges from 700 µm to 1000 µm. Find more product information and technical specifications.

The effect of administration media on palatability and ease of swallowing of multiparticulate formulations

Abstract

Multiparticulate formulations based on pellets, granules or beads, could be advantageous for paediatrics, geriatrics and patients with swallowing difficulties. However, these formulations may require suitable administration media to facilitate administration. The aim of this work was to investigate the effect of administration media properties on palatability and ease of swallowing of multiparticulates. A range of vehicles were developed using xanthan gum (XG) and carboxymethyl cellulose (CMC) as model hydrocolloids. Such vehicles were prepared at three consistency levels (Level 1 – ‘syrup’, Level 2 – ‘custard’ and Level 3 – ‘pudding’) to investigate the effect of viscosity on their performance as administration media. A randomised, single-blind sensory evaluation study was carried out in thirty healthy adult volunteers using microcrystalline cellulose pellets as model multiparticulates, dispersed in the hydrogels (and water as control) at a concentration of 250 mg in 5 ml. Samples were evaluated using 5-point scales. The use of hydrogels as administration media improved a range of sample attributes compared to water formulations, including appearance, taste, mouthfeel, ease of swallowing and residue in the mouth (all improved by ca. 0,5 points) and oral grittiness perception (improved by ca. 1 point). Polymeric hydrogels thickened to medium consistency (Level 2, XG 0.5% and CMC 1.0% w/v) demonstrated the best performance.

Reference

Article: “The effect of administration media on palatability and ease of swallowing of multiparticulate formulations”

Authors: Felipe L. Lopez, Terry B. Ernest, Mine Orlu, and Catherine Tuleu.

First published: International Journal of Pharmaceutics 2018, 551(1–2) 67-75; https://doi.org/10.1016/j.ijpharm.2018.08.021

1. Introduction

Multiparticulate formulations, in the form of pellets, granules or beads, offer a range of advantages over conventional tablets and capsules, such as ease of swallowing, flexible dose titration, and suitability for taste-masking and controlled-release (Lopez et al., 2015). They are considered a flexible solid dosage form for the delivery of drugs to a broad range of patients, including paediatrics, geriatrics and patients with swallowing difficulties. However, previous studies suggest that grittiness and rough mouthfeel perception might be a barrier to palatability and patient acceptability (Kimura et al., 2015, Lopez et al., 2018, Lopez et al., 2016). A potential solution to overcome palatability and acceptability issues could be co-administration with a suitable vehicle (i.e. sprinkle), which could help to conceal the presence of multiparticulates. Some drug products that contain multiparticulates within a capsule or sachet indicate in the labelling that the internal beads can be sprinkled on soft foods for their administration (FDA, 2012). Commercial examples include Depakote® sprinkle capsules (divalproex sodium), Creon® capsules (pancrelipase), Granupas® gastro-resistant granules in sachets (para-aminosalicylic acid) and Cipla’s lopinavir/ritonavir pellets in capsules (Hanning et al., 2016, Ternik et al., 2017). Typical vehicles recommended for products labelled for sprinkle include apple sauce and yogurt that provide both flavour and viscosity to facilitate administration and improve patient acceptability (Ternik et al., 2017).

Studies comparing sprinkle formulations to liquid dosage forms in children have commonly showed preference for the solid over the liquid form. A range of studies showed acceptance of iron supplement sprinkles and preference for these compared to oral drops in children with anaemia (Adu-Afarwuah et al., 2008, Geltman et al., 2009, Zlotkin et al., 2003). Likewise, studies involving children suffering from epilepsy consistently showed preference for sprinkle formulations over syrup (Cloyd et al., 1992, Motte et al., 2005, Verrotti et al., 2012). In a recent study, children showed preference for sprinkles over syrup after 12-week antiretroviral therapy; 72% of children below 12 months and 64% of children between 1 and 4 years preferred the multiparticulate dosage form. For those preferring syrups, key issues with sprinkles were problems masking the pellets with food and food refusal, and concerns about not giving the whole dose. However, multiparticulates overcome the storing and transporting issues of syrups (Kekitiinwa et al., 2016).

Medicines are known to be mixed with liquid and semi-solid foodstuff to allow administration in clinical practice (Akram and Mullen, 2015, Akram and Mullen, 2012). However, this is not without the risks that mixing medication with foodstuff could alter bioavailability and introduce poor control over dose intake (EMA, 2013). Therefore, when co-administration of medicines and foodstuff is recommended in the package leaflet, the potential impact on patient acceptability, dosing accuracy, compatibility and drug bioavailability of the proposed vehicle(s) must be investigated (EMA, 2013). This task becomes very impractical when medicines can be mixed with a range of foods with different composition and physical properties (e.g. rheology, pH, ionic strength) (Kersten et al., 2016). The development of a standard pharmaceutical vehicle, rationally designed and fit for purpose, could facilitate such investigations. This vehicle could be manufactured by industry and provided with the finished drug product (although this would increase the overall cost of the product) or it could be compounded in a pharmacy (Kluk and Sznitowska, 2014). Investigation into swallowing aids for the administration of oral solid formulations have been the focus of previous research, with some products already in the market in the form of sprays, pastes or jellies (Bunupuradah et al., 2006, Diamond and Lavallee, 2010, Yoshida et al., 2011).

The rheological properties of the administration media require special consideration. Thick fluids are known to exhibit prolonged oral transit times than thinner fluids, which can be used in the management of patient with dysphagia (Soares et al., 2015). Conversely, greater efforts are required to manipulate in the mouth and swallow thick fluids compared to thin ones (Ong et al., 2018, Steele et al., 2015). Consequently, overly thick liquids may increase the risk of post-swallow residue in the mouth and pharynx, especially for patients with reduced tongue or pharyngeal muscle strength (Steele et al., 2015). Newtonian fluids have also been reported to require greater effort in oral processing and swallowing than shear thinning fluids (Steele et al., 2015). In addition, the rheology of the vehicle also affects its palatability, with organoleptic attributes often reported to worsen as the consistency of the fluid increases (Garcia et al., 2005, Ong et al., 2018). Therefore, it is imperative that the rheological and sensory properties of the vehicle are adequately characterised.

The use of a suitable vehicle could facilitate administration of multiparticulates by preventing fast sedimentation, improving palatability and reducing the risk of aspiration or choking often associated with this dosage form design (Walsh et al., 2018). Development of media for the administration of multiparticulates and evaluation of its effect on palatability has been the focus of two recent studies (Kluk and Sznitowska, 2014, Lopez et al., 2016), both of which concluded that the use of polymeric hydrogels as administration media could help conceal the presence of particles, reducing oral grittiness perception. However, both studies focussed on a swirl and spit methodology, which overlooks other important sample attributes such as ease of swallowing. Moreover, neither of those studies investigated the palatability of the liquid vehicles alone, which limited their understanding on the effect of the palatability of the vehicle on the overall palatability and acceptability of the final formulations.

The aim of this work was to develop liquid vehicles for the administration of multiparticulates and to investigate the effect of the administration media properties on palatability and ease of swallowing of multiparticulate formulations. Administration media were developed using xanthan gum (XG) and carboxymethyl cellulose (CMC) as model hydrocolloids. The rheological properties of the hydrocolloids were characterised to investigate the effect of consistency and shear thinning behaviour on their performance as administration media. Palatability attributes and ease of swallowing of the vehicles alone and formulations containing model multiparticulates were evaluated in healthy volunteers.

2. Materials and methods

2.1. Materials

Microcrystalline cellulose pellets (CELLETS® 200 and CELLETS® 700) were provided by Pharmatrans Sanaq (Basel, Switzerland). Xanthan gum (“XG”, Xantural 180, 1% gum in 1% KCl aqueous solution: 1200–1600 cP) was supplied by CP Kelco (Leatherhead, Surrey, UK); sodium carboxymethyl-cellulose (“CMC”, Blanose 7HF-PH, 1% aqueous solution: 1500–2500 cP) was provided by Ashland (Covington, Kentucky, USA); and vanillin was procured from Sigma-Aldrich (Irvine, Ayrshire, UK).

2.2. Preparation of administration media

Polymeric hydrogels in the range of 0.15–1.50% (w/v) were prepared by slow addition of hydrophilic polymer (XG or CMC) into 100 ml of water under continuous stirring at room temperature. Previous research indicate that some hydrocolloids may impart a noticeable foreign taste or off-flavour to water and other liquid vehicles (Matta et al., 2006, Ong et al., 2018, Pelletier, 1997, Saha and Bhattacharya, 2010). For this reason, a small amount of vanillin (0.1% w/v) was added to mask any potential taste and smell of the polymers which could negatively impact results. Samples were left stirring overnight to ensure complete polymer hydration and stored in the refrigerator at 5 ± 0.5 °C. Samples were allowed to equilibrate to room temperature before testing.

For the sensory evaluation study, the viscosity of the XG and CMC vehicles were targeted to meet the International Dysphagia Diet Standardisation Initiative (IDDSI) descriptors (Cichero et al., 2017, IDDSI, 2015). According to this framework, Level 1 fluids are “thicker than water but flow through a teat/nipple and straw”, Level 2 fluids “require effort to drink through a straw and flow quickly off a spoon” and Level 3 fluids are “difficult to suck through a straw and pour slowly off a spoon”.

2.3. Rheological characterisation

A Bohlin CVO rotational rheometer system (Malvern Instruments Ltd, Malvern, UK) was used to investigate the flow properties of the samples using a cone and plate geometry (40 mm diameter, 4° angle; gap size adjusted to 250 µm). A shear sweep measurement mode was employed, whereby the shear rate of the sample was advanced across the range of 0.1–200 s−1, with ascendant logarithmic progression. The temperature of the samples was maintained at 25 ± 0.2 °C throughout testing. This procedure was repeated three times for each sample.

The resulting data (shear rate vs. shear stress) was fitted to the power law model (Eq. (1)) to describe the flow properties of the samples:(1)σ=Kγnwhere σ is the shear stress (Pa), γ is the shear rate (1/s), K is the consistency index (Pas), and n is the flow behaviour index (dimensionless). The consistency index (K) corresponds to the viscosity at a shear rate of 1 s−1; whereas the flow behaviour index (n) provides an indication of the deformation behaviour, where a value of 1 indicates Newtonian behaviour, 0–1 indicates shear-thinning behaviour and values greater than 1 indicate shear-thickening (O’Leary et al., 2010). In addition, the apparent viscosity at 50 s−1 (ƞ at 50 s−1), a reference shear rate for oral processing and swallowing, and the apparent viscosity at 0.1 s−1 (ƞ at 0.1 s−1), a reference shear rate of the sample at rest, were measured by the rheometer along the ascendant shear ramp.

2.4. Sedimentation experiments

The ability of the administration media to maintain multiparticulates in suspension was calculated based on sedimentation experiments. A sample containing 500 mg of CELLETS® and 50 ml of administration media was filled into a 50-ml graduated plastic tube. The tube was turned upside down until homogeneous dispersion of the particles. Then, the sample was left standing and the time taken for CELLETS® to clarify the top 15 ml of the dispersant (approximately one third of the media volume) was determined. This experiment was adapted from that described by Kluk and co-workers (Kluk and Sznitowska, 2014). Experiments were repeated using multiparticulates of two extreme particle sizes, CELLETS® 200 (200–355 µm) and CELLETS® 700 (700–1000 µm), to account for the effect of particle size on sedimentation. The experiment was conducted in triplicate.

2.5. Sensory evaluation study

2.5.1. Study design

Thirty healthy adult volunteers (aged 19–33 years, average 23.2 ± 4.4 years; 21 females) were enrolled in a randomised, single-blind, single-centre, 3-treatment, crossover sensory evaluation. The study was approved by UCL Research Ethics Committee (Project ID: 4612-011). All participants received a detailed information sheet and provided written consent to participate in the study. The study was conducted in three sessions taken place on three separate days. On each day, participants tested samples of liquid vehicles without particles (T1: ‘no particles’), with 200–355 µm particles (T2: ‘smaller particles’) and with 700–1000 µm particles (T3: ‘larger particles’). Participants were divided into six groups to ensure that all possible sequence orders between treatments were considered. In each session, participants were handed eight samples, including XG and CMC samples and water as a control (Table 1), in a randomised order.

table-1

Table 1. List of liquid vehicles assessed in sensory evaluation experiments.

For samples containing multiparticulates, 250 mg of solid particles were pre-dispersed in the administration media (approximately 3 ml, for a total volume of 5 ml) using a spatula immediately before administration. Microcrystalline cellulose pellets used in this investigation were non-disintegrating in water or in the mouth. Samples were provided onto 5-ml plastic medicine spoons that were handed to participants of the study. During the evaluation of the samples, participants had free access to spring water to complete sample intake and clean their palate. To minimise subject discomfort and carryover effect 5–10-minute intervals were respected between samples.

2.5.2. Evaluation tool and outcome measures

A digitalized questionnaire (Qualtrics.com) was used for data collection. Immediately after swallowing the sample, volunteers were asked to rate several sample attributes, including appearance, ease of swallowing, mouth-feel and taste, using a 5-point hedonic scale (1 – extremely liked, 5 – extremely disliked). In addition, the feeling of particles in the mouth during sample intake (i.e. grittiness perception) and the feeling of particles in the mouth after sample intake and after rinsing their mouth with water (i.e. residue in mouth) was assessed using a 5-point magnitude scale (1 – not perceptible, 5 – extremely perceptible). Participants could also provide voluntary feedback of each sample attribute using their own words.

2.5.3. Data analysis

The different categories of the 5-point scales were assigned numeric scores (1–5) from lowest to highest stimuli perception, respectively. Statistical analysis was performed using the non-parametric Kruskal-Wallis one-way analysis of variance followed by Dunn’s test as post hoc for pairwise comparison, both with a 95% confidence level. Minitab 17 (Minitab Inc., State College, Pennsylvania, USA) was used for data analysis.

3. Results and discussion

3.1. Development of administration media for multiparticulates

3.1.1. Rheological properties

The rheological properties of the administration media require especial attention as these will have an impact on several critical quality attributes, such as suspendability and palatability (particularly appearance and mouth-feel). XG and CMC were selected as model excipients to develop polymeric hydrogels for the administration of multiparticulates, being Generally Regarded As Safe (GRAS) excipients commonly used in oral formulations.

The rheological properties of XG and CMC hydrogels were investigated as a function of the hydrocolloid concentration (Table 2). The consistency index of XG and CMC-based polymeric hydrogels increased as the hydrocolloid concentration increased, as it can be expected. The increase in viscosity was more pronounced for XG than it was for CMC, revealing the higher ‘thickening power’ of XG. In addition, XG hydrogels exhibited a strong shear thinning behaviour whereas CMC hydrogels showed a much lower degree of shear thinning; the flow behaviour index (n-value) of XG-based hydrogels was lower than that of CMC-based hydrogels throughout the range of concentrations tested.

table-2

Table 2. Rheological characteristics of XG and CMC hydrogels prepared at concentrations 0.15–1.50% w/v.

The contrasting rheological characteristics of XG and CMC made them ideal candidates to investigate the effect of shear thinning behaviour on their performance as administration media for the administration of multiparticulates. Previous research indicate that Newtonian fluids require greater effort in oral processing and swallowing than shear thinning fluids (Steele et al., 2015). However, it could be hypothesised that shear thinning fluids would be less effective in ‘masking’ the presence of particles since the viscosity of these fluids will decrease under the relatively high shear rates experienced during oral processing (50–300 s−1) (Steele et al., 2015).

3.1.2. Ability to maintain multiparticulates in suspension

An ideal vehicle should be able to maintain multiparticulates in suspension from dispersion of the particles in the media until administration. Sedimentation time of multiparticulates in polymeric hydrogels was determined by measuring the time lapse between homogeneous dispersion of multiparticulates and clearance of the top layer of the liquid vehicle. Results of sedimentation time as a function of the media viscosity are summarised in Table 3. The time needed for manipulation and administration of a medicine is usually less than 5 min but can take longer than 10 min in some cases (Ruiz et al., 2016), thus appropriate administration media should maintain multiparticulates in suspension for at least 10–15 min.

table-3

Table 3. Sedimentation time (minutes) of CELLETS® 200 and CELLETS® 700 in XG and CMC hydrogels.

Sedimentation time increased with increasing viscosity of the media and decreased with increasing size of the multiparticulates, in accordance to Stoke’s law. XG hydrogels prepared at 0.25% w/v would be sufficient to maintain both 200–355 and 700–1000 µm particles in suspension for at least 10–15 min, whereas a higher concentration of CMC (1.00% w/v) would be required to maintain the larger particles in suspension for the same time. The lower concentration of XG required to maintain multiparticulates in suspension could be expected based on its stronger thickening power and its shear thinning character, which means that the viscosity of XG hydrogels at low shear rates (i.e. shear rates relevant during sedimentation) is higher than that of CMC hydrogels.

3.2. Sensory evaluation studies

3.2.1. Liquid vehicles without multiparticulates

Participants of the sensory evaluation study tested liquid vehicles without multiparticulates in one of the three sessions of the study. The analysis of liquid vehicles without multiparticulates was performed in order to gain fundamental understanding of the properties of the liquid vehicles, such as appearance, mouthfeel, taste and ease of swallowing.

All samples evaluated received average appearance ratings in the neutral to positive range of the scale, except for XG L3 (average appearance rating = 3.17). According to participants responses to hedonic scales, the appearance of XG hydrogels was worse than the appearance of water and CMC hydrogels (p < 0.001), as shown in Fig. 1. This was adscribed to the opaque appearance of XG hydrogels (in contrast with the transparent aspect of water and CMC hydrogels), as supported by anecdotal feedback provided by the participants: e.g. “I personally prefer when the sample is limpid, this one was a bit opaque and it gives you an idea of dirt” (Participant 11, XG L3). Appearance ratings worsened as the consistency level increased. This indicates that the appearance of very thick samples (which retain their shape when placed on a spoon) was considered less appealing than thinner fluids.

swallowing of multiparticulate formulations_fig-1

Fig. 1. Interval plot for appearance, mouthfeel, taste and ease of swallowing of different liquid vehicles. Markers represent the population mean for the hedonic ratings (where 1 is the best possible rating and 5 is the worst possible rating) and bars show the 95% CI for the mean. Water + v. represents water to which 0.1% w/v vanillin was added; the consistency level of XG and CMC hydrogels is described as L1 (Level1), L2 (Level 2) and L3 (Level 3).

The taste of all liquid vehicles evaluated received average ratings between 2 and 3 (range: 2.33–2.63; XG L1 – Water), which indicates acceptable neutral taste (Fig. 1). The very small differences between samples confirmed that the level of vanillin used was appropriate to mask any potential foreign taste from the polymer without having a significant impact on results (as it was intended). However, the fact that average ratings for taste were closer to the centre of the scale than to the positive end of the scale may indicate participants’ expectations of a more intense, sweetened or flavoured taste for samples intended as a medicinal product. This was reinforced by voluntary feedback; e.g. “if this had added sugar/sweetener it would be a more enjoyable medicine to take” (P05, CMC L3).

Mouthfeel ratings of XG and CMC hydrogels worsened as the consistency of the sample increased, revealing preference for thinner vehicles (Fig. 1). This is consistent with previous research which reported that thinner fluids are perceived as less viscous, less adhesive and easier to manipulate in the mouth than thicker fluids (Ong et al., 2018). However, all samples received average ratings in the neutral to positive range of the scale (range: 1.67–2.90), suggesting all vehicles prepared had an acceptable mouthfeel to be used as media for the administration of multiparticulates. CMC hydrogels received slighly worse mouthfeel ratings than XG samples, which was attributed to a “greasy” or “oily” feeling in the mouth, as reported by the volunteers. The mouth-coating texture of CMC hydrogels has been reported in previous research and attributed to its low degree of shear thinning (high n-value) (Cho et al., 2015, Szczesniak and Farkas, 1962). On the contrary, xanthan gum samples have been perceived as less adhesive and easier to manipulate in the mouth (Ong et al., 2018). Nevertheless, mouthfeel differences between XG and CMC vehicles were not statistically significant, despite their contrasting rheological profiles. The inability to clearly identify preference between samples can be explained by consumers, including patients, having different criteria for personal preferences (Matta et al., 2006).

All samples evaluated were considered ‘easy to swallow’ by healthy volunteers, receiving average ratings in the neutral to positive range of the scale (range: 1.07–2.57). However, samples were considered relatively more difficult to swallow as the consistency level increased (p < 0.001), as depicted in Fig. 1. This can be attributed to the greater effort required to convey thicker fluids through the oral cavity and greater effort required for the throat muscles to swallow thicker fluids (Ong et al., 2018). In their open-ended feedback, participants described the need to swallow repetitively to achieve full ingestion of thicker samples; e.g. “the sample is very viscous and is difficult to swallow, it remains in my mouth after swallowing a few times” (P22, CMC L3). This is in line with previous research as thicker liquids have been shown to increase the risk of post-swallow residue in the mouth and pharynx (Steele et al., 2015). It is also well established that fluids with higher viscosity exhibit prolonged oral transit times as compared to thinner fluids such as water (Soares et al., 2015). Moreover, the ratings of ease of swallowing indicate that XG hydrogels were slightly easier to swallow than CMC hydrogels (p < 0.018), which was supported by anecdotal feedback; e.g. “this sample (CMC L2) is more difficult than the previous one (XG L2) in swallowing it as a whole, as it remains in my mouth after the first swallow” (P10, CMC L2). This can be explained by the stronger shear thinning behaviour of XG hydrogels. Shear thinning fluids can be expected to be easier to swallow due to lower resistance to flow under shear (Ong et al., 2018, Steele et al., 2015).

3.2.2. Multiparticulates dispersed in liquid vehicles

The appearance of multiparticulate samples dispersed in different vehicles received average ratings around the neutral range of the scale (range: 2.70–3.40), as shown in Fig. 2. The size of the multiparticulates had no influence on the ratings of appearance (p = 0.074), whereas the vehicle used had a significant impact on the appearance of the final formulation (p < 0.001). The appearance of samples dispersed in polymeric hydrogels (2.96 for XG and 2.77 for CMC hydrogels, on average) was considered better than that of samples dispersed in water (3.33 with and 3.40 without vanillin). This was explained by the more homogenous appearance of samples dispersed in thickened vehicles as compared to multiparticulates dispersed in water. Multiparticulates precipitated very quickly in water, due to its very low viscosity, leading to heterogenous samples with particles settled down on the bottom of the spoon. On the contrary, CELLETS® remained homogeneously dispersed in thicker hydrogels, which was considered a positive feature by the volunteers. Moreover, samples prepared in XG vehicles thickened to the highest consistency were rated more negatively than samples dispersed in other hydrogels, which can be expected based on the negative ratings of appearance received by this vehicle when evaluated on its own.

swallowing of multiparticulate formulations_fig-2

Fig. 2. Interval plot for appearance, taste, mouthfeel and ease of swallowing as a function of the vehicle used as suspending media and the size of the dispersed multiparticulates: 200–355 µm (CELLETS® 200) or 700–1000 µm (CELLETS® 700). Markers represent the population mean for the hedonic ratings (where 1 is the best possible rating and 5 is the worst possible rating) and bars show the 95% CI for the mean. Water + v. represents water to which 0.1% w/v vanillin was added; the consistency level of XG and CMC hydrogels is described as L1 (Level1), L2 (Level 2) and L3 (Level 3).

The taste of the samples worsened when multiparticulates where added into the formulation and when the multiparticulate size increased (Fig. 2); from 2.44 on average without presence of multiparticulates to 2.63 and 2.89 on average with smaller and larger multiparticulates, respectively. In addition, the taste of formulations with vanilla flavour was deemed better than the taste of samples prepared with pure water (p < 0.001). On the contrary, no significant differences were found between XG and CMC samples in terms of taste which, again, confirmed the successful masking of any potential inherent taste of the polymer by addition of a small quantity of vanillin. Although microcrystalline cellulose pellets are expected to be tasteless, negative taste ratings in hedonic scales have been previously reported and attributed to the poor mouthfeel of the formulation (Lopez et al., 2018). This can be explained by a common cognitive bias in sensory evaluation by which perception of a salient attribute influences the ratings of other (independent) sample attributes (Clark and Lawless, 1994).

The mouthfeel of multiparticulates dispersed in liquid vehicles also received average ratings around the neutral range of the scale (Fig. 2). Both the size of the multiparticulates and the vehicle used to disperse them had a significant impact on mouthfeel of the final formulation (p = 0.001 and p < 0.001, for size and vehicle, respectively). The mouthfeel of samples containing smaller multiparticulates was on average 0.30 points better than that of samples containing larger multiparticulates. An increasing grittiness sensation or rough mouthfeel with increasing size of the multiparticulates have also been reported on previous studies (Kimura et al., 2015, Kluk and Sznitowska, 2014, Lopez et al., 2018, Lopez et al., 2016). In terms of the vehicle used, participants showed preference for samples dispersed in thickened vehicles over samples dispersed in water. In addition, participants preferred the samples with low and middle-range consistencies (Level 1 and Level 2) over the extremely thick ones (Level 3). According to the participants of the study, those samples achieved a good balance by “concealing the presence of particles in the mouth” but not being too thick (which has a detrimental impact on mouthfeel). Samples thickened to Level 1 and Level 2 consistencies were rated on average 0.62 and 0.54 points better than water, respectively, whereas samples with Level 3 consistency were rated only 0.34 points better than water, on average.

As depicted in Fig. 2, swallowing of multiparticulates was considered more difficult with increasing particle size, from 2.36 on average for smaller multiparticulates to 2.91 on average for larger multiparticulates (p < 0.001). Multiparticulates dispersed in polymeric hydrogels were easier to swallow than multiparticulates dispersed in water (by approximately 0.50 points), irrespectively of the size of the particles. Both XG and CMC hydrogels were similarly efficient in facilitating swallowing of the multiparticulates (2.52 and 2.49 on average, respectively). Therefore, no significant differences were found between XG and CMC hydrogels in terms of ease of swallowing when administered with multiparticulates, despite their different rheological properties and the differences found when administered without multiparticulates. This might indicate that the sensory properties of the samples were dominated by the presence of particles in suspension at relatively high concentration (Mueller et al., 2010), thus differences between vehicles became negligible. The rheological properties of the samples could be dramatically affected by addition of multiparticulates; the inclusion of the solid particles is expected to produce and increase in consistency and in shear thinning behaviour (Mueller et al., 2010). In agreement with the results for mouthfeel perception, participants showed preference for swallowing samples with thin and middle-range consistencies (Levels 1 and 2) as opposed to thicker samples. These samples performed best at “carrying the particles together” as a bolus and “providing cushioning”, facilitating swallowing, while not being too thick to “linger around” in the oral cavity for long. The contrast between samples of different consistency was reported in open-ended responses; e.g.: “the liquid in this sample was too runny and was unable to carry the particles along with it, so the liquid part was consumed first, leaving behind the solid part of the sample” (P02, CELLETS® 200 in Water); or “I feel that this sample has the correct viscosity that is able to hold the particles together and is able to be easily swallowed” (P10, CELLETS® 200 in XG L1).

As discussed above, grittiness perception increased with increasing size of the multiparticulates (p < 0.001) in agreement with previous studies (Kimura et al., 2015, Kluk and Sznitowska, 2014, Lopez et al., 2018, Lopez et al., 2016); samples of smaller multiparticulates obtained an average grittiness score of 2.50 compared to 3.31 scored on average by samples containing larger multiparticulates. The feeling of residual particles in the mouth also increased with increasing size of the multiparticulates, 1.67 on average for CELLETS® 200 compared to 2.14 on average for CELLETS® 700 (Fig. 3). Participants ratings of ‘grittiness perception’ confirmed the results obtained for mouthfeel and ease of swallowing in that polymeric hydrogels masked the presence of multiparticulates. Grittiness perception was lower for polymeric hydrogel formulations than for samples dispersed in water by approximately 1.0 point, on average, both for smaller and larger multiparticulates. This was supported by voluntary feedback; e.g. “without a thick solution to act as a lubricant and carry the particles along with it, the ‘grainy’ feeling was enhanced, making it very unpleasant to take” (P02, CELLETS® 200 in water); compared to samples in thickened vehicles, e.g. “it is viscous, but that masks the overall ‘particles feel’, which is good” (P12, CELLETS® 200 in CMC L2). The use of polymeric hydrogels to disperse multiparticulates also reduced the ‘residue in mouth’, i.e. the feeling of particles in the mouth after swallowing (p < 0.001), for multiparticulates of both sizes evaluated. The residual feeling of particles was reduced by approximately 0.5 points on average when using polymeric hydrogels as vehicles, as compared to water.

swallowing of multiparticulate formulations_fig-3

Fig. 3. Interval plot for grittiness and residue of multiparticulates in mouth after swallowing as a function of the vehicle used as suspending media and the size of the multiparticulates: 200–355 µm (CELLETS® 200) or 700–1000 µm (CELLETS® 700). Markers represent the population mean for the 5-point magnitude scale (where 1 is the lowest possible and 5 is the highest possible intensity of the stimulus) and bars show the 95% CI for the mean. Water + v. represents water to which 0.1% w/v vanillin was added; the consistency level of XG and CMC hydrogels is described as L1 (Level1), L2 (Level 2) and L3 (Level 3).

According to the ratings on the 5-point scale, no significant differences were found between XG and CMC hydrogels in their ability to mask the grittiness of particles, either during sample intake or after swallowing of the samples; although the trend suggests that CMC vehicles performed better when using multiparticulates of larger size. As previously discussed, this indicates that the sensory properties of the samples were dominated by the presence of multiparticulates rather than the shear thinning behaviour of the vehicles. Moreover, no significant differences were found between vehicles thickened to different consistency levels based on scale ratings, although anecdotal feedback indicated that thicker hydrogels performed better than thinner vehicles in terms of masking the presence of particles, e.g. “less thick than other samples, thus I can feel the particles when I swallowed it; need to drink water to remove the particles” (P16, CELLETS® 200 in XG L1). Disagreement between grittiness ratings and voluntary feedback suggests that scale ratings were influenced by the overall appreciation of the sample, an issue commonly encountered in sensory evaluation studies (Clark and Lawless, 1994, Prescott et al., 2011). As the concentration of hydrocolloid in de sample increased, the perception of particles decreased but other organoleptic attributes worsened. As such, mouthfeel and grittiness perception were driven by a balance between those opposing phenomena, which explains the similar ratings obtained by samples of different consistency despite their different organoleptic attributes. These findings highlight the multifactorial nature of palatability and mouthfeel perception which poses a challenge to evaluate sample attributes independently (Clark and Lawless, 1994, Popper et al., 2004, Prescott et al., 2011).

The results of these trial are summarised in Fig. 4, where the radar charts show the mean result for each palatability attribute as a function of the size of the multiparticulates and the administration media (water with vanillin, which was used as a control, was excluded from the graphs to aid clarity). The use of polymeric hydrogels as administration media resulted in an overall improvement of the samples: appearance, taste, mouthfeel, ease of swallowing and residue in the mouth improved by ca. 0.5 points, and oral grittiness perception improved by ca. 1 point. Overall, polymeric hydrogels thickened to medium consistency (Level 2) demonstrated the best performance by virtue of their ability to conceal the grittiness of multiparticulates in the mouth and to aid swallowing of the formulation as a bolus, while maintaining a balanced consistency (not too thick) to ensure appropriate mouthfeel. These findings were in line with previous research in the field in that vehicles of very thick consistency tend to be disliked despite their ability to mask the presence of multiparticulates in the formulation (Kluk and Sznitowska, 2014, Lopez et al., 2016). Further investigation of the physicochemical properties of the samples, such as adhesiveness, ductility and lubrication properties could provide a more rigorous insight into the physical drivers for mouthfeel perception (Stokes et al., 2013). Differences in palatability and acceptability can be expected in different sub-sets of the population (Lopez et al., 2018, Mennella et al., 2012), thus future work should investigate the acceptability of these vehicles in paediatrics and patients with swallowing difficulties, those who could benefit the most from these formulations.

swallowing of multiparticulate formulations_fig-4

Fig. 4. Radar chart for appearance, taste, grittiness, mouthfeel, ease of swallowing and residue of multiparticulates in mouth as a function of the vehicle used as suspending media and the size of the multiparticulates: 200–355 µm (CELLETS® 200) or 700–1000 µm (CELLETS® 700). Each palatability item is described by its population mean for the 5-point scale (where 1 is the lowest possible and 5 is the highest possible intensity of the stimulus). The consistency level of XG and CMC hydrogels is described as L1 (Level1), L2 (Level 2) and L3 (Level 3).

4. Conclusion

The use of hydrogels as administration media for multiparticulates improved a range of sample attributes compared to water formulations, including appearance, taste, mouthfeel, ease of swallowing and grittiness perception during and after sample intake. This improvement was apparent for samples containing multiparticulates of both sizes investigated (those over 200 and those over 700 µm). Polymeric hydrocolloids provided ‘cushioning and lubrication’ of the particles and acted as an effective vehicle by ‘carrying the particles together’, concealing the gritty feeling of the multiparticulates and assisting swallowing. Participants also reported that additional intake of water after administration of the gel formulation was beneficial to facilitate swallowing of the full dose of multiparticulates. Polymeric hydrogels thickened to medium consistency (Level 2, XG 0.5% and CMC 1.0% w/v) were preferred over either thinner or thicker vehicles. A balanced consistency reduced the gritty feeling of multiparticulates while not being overly thick, which would hinder sensory attributes. Meanwhile, differences between XG and CMC hydrogels were minimal despite their opposing shear thinning behaviour. These findings suggest that the consistency of the vehicle was an attribute of greater importance than its shear thinning behaviour. However, XG brings the added value of its strong thickening power, requiring very low concentrations to produce hydrogels of adequate consistency. Results of this study indicate that polymeric hydrogels could be used to improve palatability, facilitate swallowing and enhance patient acceptability of multiparticulate formulation.

5. Author contribution statement

Felipe L. Lopez: Methodology, Investigation, Formal Analysis, Visualization, Writing- Original draft preparation. Terry B. Ernest: Funding Acquisition, Conceptualization, Methodology, Supervision, Writing – Review & Editing. Mine Orlu: Funding Acquisition, Conceptualization, Methodology, Supervision, Writing – Review & Editing. Catherine Tuleu: Funding Acquisition, Conceptualization, Methodology, Validation, Supervision, Writing – Review & Editing.

Acknowledgement

The authors are grateful to the EPSRC for providing funding through a studentship within the CDT in Targeted Therapeutics and Formulation Sciences (EPSRC grant: EP/I01375X/1).

Conflict of interest statement

The authors declare no conflict of interest other than their disclosed affiliations and acknowledged funding.

Appendix A. Supplementary data

Supplementary data associated with this article can be found, in the online version, at https://doi.org/10.1016/j.ijpharm.2018.08.021.

License

Creative Commons license CC BY 4.0.

References

Adu-Afarwuah, S., Lartey, A., Brown, K.H., Zlotkin, S., Briend, A., Dewey, K.G., 2008. Home fortification of complementary foods with micronutrient supplements is well accepted and has positive effects on infant iron status in Ghana. Am. J. Clin. Nutr. 87, 929–938.

Akram, G., Mullen, A.B., 2015. Mixing medication into foodstuffs: identifying the issues for paediatric nurses. Int. J. Nurs. Pract. 21, 125–131. https://doi.org/10.1111/ijn.12222.

Akram, G., Mullen, A.B., 2012. Paediatric nurses’ knowledge and practice of mixing medication into foodstuff. Int. J. Pharm. Pract. 20, 191–198. https://doi.org/10.1111/j.2042-7174.2011.00179.x.

Bunupuradah, T., Wannachai, S., Chuamchaitrakool, A., Intasan, J., Nuchapong, T., Neiss, W., Kramm, K., Pancharoen, C., Burger, D., Ananworanich, J., 2006. Use of tastemasking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals. AIDS Res. Ther. 3, 30. https://doi.org/10.1186/1742-6405-3-30.

Cho, H., Yoo, W., Yoo, B., 2015. In: Effect of NaCl Addition on Rheological Behaviors of Commercial Gum-Based Food Thickener Used for Dysphagia Diets, pp. 137–142. https://doi.org/https://doi.org/10.3746/pnf.2015.20.2.137.

Cichero, J.A.Y., Lam, P., Steele, C.M., Hanson, B., Chen, J., Dantas, R.O., Duivestein, J., Kayashita, J., Lecko, C., Murray, J., Pillay, M., Riquelme, L., Stanschus, S., 2017. Development of international terminology and definitions for texture-modified foods and thickened fluids used in dysphagia management: the IDDSI framework. Dysphagia 32, 293–314. https://doi.org/10.1007/s00455-016-9758-y.

Clark, C., Lawless, H.T., 1994. Limiting response alternatives in time-intensity scaling: an examination of the halo-dumping effect. Chem. Senses 19, 583–594. https://doi.org/10.1093/chemse/19.6.583.

Cloyd, J.C., Kriel, R.L., Jones-Saete, C.M., Ong, B.Y., Jancik, J.T., Remmel, R.P., 1992. Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference. J. Pediatr. 120, 634–638. https://doi.org/10.1016/S0022-3476(05)82496-5.

Diamond, S., Lavallee, D.C., 2010. Experience with a pill-swallowing enhancement aid. Clin. Pediatr. (Phila) 49, 391–393. https://doi.org/10.1177/0009922809355313. EMA, 2013. Guideline on pharmaceutical development of medicines for paediatric use [WWW Document]. URL  http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002.pdf.

FDA, 2012. Guidance for Industry Size of Beads in Drug Products Labeled for Sprinkle Guidance for Industry Size of Beads in Drug Products Labeled for Sprinkle.

Garcia, J.M., Chambers IV, E., Matta, Z., Clark, M., 2005. Viscosity measurements of nectar- and honey-thick liquids: product, liquid, and time comparisons. Dysphagia 20, 325–335. https://doi.org/10.1007/s00455-005-0034-9.

Geltman, P.L., Hironaka, L.K., Mehta, S.D., Padilla, P., Rodrigues, P., Meyers, A.F., Bauchner, H., 2009. Iron supplementation of low-income infants: a randomized clinical trial of adherence with ferrous fumarate sprinkles versus ferrous sulfate drops. J. Pediatr. 154. https://doi.org/10.1016/j.jpeds.2008.11.003.

Hanning, S.M., Lopez, F.L., Wong, I.C.K., Ernest, T.B., Tuleu, C., Orlu Gul, M., 2016. Patient centric formulations for paediatrics and geriatrics: similarities and differences. Int. J. Pharm. 512, 355–359. https://doi.org/https://doi.org/10.1016/j.ijpharm.2016.03.017.
IDDSI, 2015. Detailed Descriptors, Testing Methods and Evidence – Drinks: Levels 0-4 [WWW Document]. URL http://iddsi.org/framework/.

Kekitiinwa, A., Musiime, V., Thomason, M.J., Mirembe, G., Lallemant, M., Nakalanzi, S., Baptiste, D., Walker, A.S., Gibb, D.M., Judd, A., Judd, A., 2016. Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children. Antiviral Ther. https://doi.org/10.3851/IMP3054.

Kersten, E., Barry, A., Klein, S., 2016. Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children. Pharmazie 71, 122–127. https://doi.org/10.1691/ph.2016.5145.

Kimura, S., Uchida, S., Kanada, K., Namiki, N., 2015. Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets. Int. J. Pharm. 484, 156–162. https://doi.org/10.1016/j.ijpharm.2015.02.023.

Kluk, A., Sznitowska, M., 2014. Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients. Int. J. Pharm. 460, 228–233.  https://doi.org/10.1016/j.ijpharm.2013.10.052.

Lopez, F.L., Bowles, A., Gul, M.O., Clapham, D., Ernest, T.B., Tuleu, C., 2016. Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers. Eur. J. Pharm. Sci. 92, 156–162. https://doi.org/10.1016/j.ejps.2016.07.006.

Lopez, F.L., Ernest, T.B., Tuleu, C., Gul, M.O., 2015. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opin. Drug Deliv. 12, 1727–1740. https://doi.org/10.1517/17425247.2015.1060218.

Lopez, F.L., Mistry, P., Batchelor, H.K., Bennett, J., Coupe, A., Ernest, T.B., Orlu, M., Tuleu, C., 2018. Acceptability of placebo multiparticulate formulations in children and adults. Sci. Rep. 1–10. https://doi.org/10.1038/s41598-018-27446-6.

Matta, Z., Chambers IV, E., Garcia, J.M., Helverson, J.M.G., 2006. Sensory characteristics of beverages prepared with commercial thickeners used for dysphagia diets. J. Am. Diet. Assoc. 106, 1049–1054. https://doi.org/10.1016/j.jada.2006.04.022.

Mennella, J.A., Finkbeiner, S., Reed, D.R., 2012. The proof is in the pudding: children prefer lower fat but higher sugar than do mothers. Int. J. Obes. 36, 1285–1291. https://doi.org/10.1038/ijo.2012.51.

Motte, J., Pedespan, J.M., Sevestre, M., Chiron, C., 2005. Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old. Arch. Pediatr. 12, 1533–1539. https://doi.org/10.1016/j.arcped.2005.07.009.

Mueller, S., Llewellin, E.W., Mader, H.M., 2010. The rheology of suspensions of solid particles. Proc. R. Soc. 466, 1201–1228. https://doi.org/10.1007/BF01432034.

O’Leary, M., Hanson, B., Smith, C., 2010. Viscosity and non-Newtonian features of thickened fluids used for dysphagia therapy. J. Food Sci. 75, E330–E338. https://doi.org/10.1111/j.1750-3841.2010.01673.x.

Ong, J.J.X., Steele, C.M., Duizer, L.M., 2018. Sensory characteristics of liquids thickened with commercial thickeners to levels specified in the International Dysphagia Diet Standardization Initiative (IDDSI) framework. Food Hydrocoll. 79, 208–217. https://doi.org/10.1016/j.foodhyd.2017.12.035.

Pelletier, C.A., 1997. A comparison of consistency and taste of five commercial thickeners. Dysphagia 12, 74–78. https://doi.org/10.1007/PL00009522.

Popper, R., Rosenstock, W., Schraidt, M., Kroll, B.J., 2004. The effect of attribute questions on overall liking ratings. Food Qual. Prefer. 15, 853–858. https://doi.org/10.1016/j.foodqual.2003.12.004.

Prescott, J., Lee, S.M., Kim, K.O., 2011. Analytic approaches to evaluation modify hedonic responses. Food Qual. Prefer. 22, 391–393. https://doi.org/10.1016/j.foodqual.2011.01.007.

Ruiz, F., Vallet, T., Pensé-Lhéritier, A.-M., Aoussat, A., 2016. Standardized method to assess medicines’ acceptability: focus on paediatric population. J. Pharm. Pharmacol. https://doi.org/10.1111/jphp.12547.

Saha, D., Bhattacharya, S., 2010. Hydrocolloids as thickening and gelling agents in food: a critical review. J. Food Sci. Technol. 47, 587–597. https://doi.org/10.1007/s13197-010-0162-6.

Soares, T.J., Moraes, D.P., de Medeiros, G.C., Sassi, F.C., Zilberstein, B., de Andrade, C.R.F., 2015. Oral transit time: a critical review of the literature. Arq. Bras. Cir. Dig. 28, 144–147. https://doi.org/10.1590/S0102-67202015000200015.

Steele, C.M., Alsanei, W.A., Ayanikalath, S., Barbon, C.E.A., Chen, J., Cichero, J.A.Y., Coutts, K., Dantas, R.O., Duivestein, J., Giosa, L., Hanson, B., Lam, P., Lecko, C., Leigh, C., Nagy, A., Namasivayam, A.M., Nascimento, W.V., Odendaal, I., Smith, C.H., Wang, H., 2015. The influence of food texture and liquid consistency modification on swallowing physiology and function: a systematic review. Dysphagia 30, 2–26. https://doi.org/10.1007/s00455-014-9578-x.

Stokes, J.R., Boehm, M.W., Baier, S.K., 2013. Oral processing, texture and mouthfeel: from rheology to tribology and beyond. Curr. Opin. Colloid Interface Sci. 18, 349–359. https://doi.org/10.1016/j.cocis.2013.04.010.

Szczesniak, A.S., Farkas, E., 1962. Objective characterization of the mouthfeel of gum solutions. J. Food Sci. 27, 381–385. https://doi.org/10.1111/j.1365-2621.1962. tb00112.x.

Ternik, R., Liu, F., Bartlett, J.A., Khong, M., Cheng, D., Tan, T., Dixit, T., Wang, S., Galella, E.A., Gao, Z., Klein, S., 2017. Assessment of swallowability and palatability of oral dosage forms in children: report from an M-CERSI pediatric formulation workshop. Int. J. Pharm. https://doi.org/10.1016/j.ijpharm.2017.08.088.

Verrotti, A., Nanni, G., Agostinelli, S., Alleva, E.T., Aloisi, P., Franzoni, E., Spalice, A., Chiarelli, F., Coppola, G., 2012. Effects of the abrupt switch from solution to modified-release granule formulation of valproate. Acta Neurol. Scand. 125, 14–18. https://doi.org/10.1111/j.1600-0404.2011.01568.x.

Walsh, J., Ranmal, S.R., Ernest, T.B., Liu, F., 2018. Patient acceptability, safety and access: a balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations. Int. J. Pharm. 536, 547–562. https://doi.org/10.1016/j.ijpharm.2017.07.017.

Yoshida, M., Hazekawa, M., Haraguchi, T., Uchida, T., 2011. Influence of swallowing Aids on the adsorption and palatability of Kremezin®. Chem. Pharm. Bull. (Tokyo) 59, 434–437. https://doi.org/10.1248/cpb.59.434.

Zlotkin, S., Antwi, K.Y., Schauer, C., Yeung, G., 2003. Use of microencapsulated iron(II) fumarate sprinkles to prevent recurrence of anaemia in infants and young children at high risk. Bull. World Health Organ. 81, 108–115. https://doi.org/10.1590/S0042-96862003000200007.

Multilayered pharmaceutically active compound-small

Introduction to Multilayered Pharmaceutically Active Compound Technology

Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form represent an innovative approach to oral drug delivery. This technology combines the benefits of coated pellets with the convenience of liquid administration. Effervescent tablets are solid dosage forms that release carbon dioxide when they dissolve in water. This reaction results from the interaction between an acid source, such as citric acid, and a carbonate or bicarbonate salt. Patients consume the resulting solution or suspension immediately after preparation. Consequently, effervescent tablets improve ease of administration and often enhance patient compliance.

Pellets play an increasingly important role in modern effervescent tablet formulations. Unlike conventional powder blends, pellets can carry individual functional coatings that protect active pharmaceutical ingredients (APIs) from degradation. In addition, pellets can separate incompatible ingredients within the same dosage form. They also improve taste masking and enable modified-release properties. As a result, formulators can develop more stable and effective products. Furthermore, pellet-containing effervescent tablets often reduce gastrointestinal irritation and improve dose uniformity. These advantages benefit both the final pharmaceutical product and the patient.

Multilayered pharmaceutically active compound-large

Multilayered pharmaceutically active compound-large

Summary of EP3117824A1

The European patent EP3117824A1 describes a drug delivery platform based on multilayered pharmaceutically active compound-releasing microparticles suspended in a liquid dosage form. The invention addresses a major challenge in pharmaceutical formulation. Many controlled-release and enteric-coated particles lose functionality when they remain in contact with water for extended periods. Therefore, maintaining stability during storage becomes difficult.

The patented technology uses microparticles that contain an API-loaded core surrounded by multiple functional coating layers. A controlled-release or enteric coating forms the intermediate layer. An additional outer protective layer surrounds this coating. The inventors designed this outer layer from a combination of hydrophilic and hydrophobic materials. Consequently, the layer protects the underlying release-controlling membrane from premature exposure to the liquid environment.

During storage, the protective coating minimizes drug leakage and preserves the integrity of the controlled-release system. As a result, the microparticles maintain their desired release characteristics for extended periods. Once the patient administers the formulation, the outer coating dissolves rapidly in the stomach. Subsequently, the underlying controlled-release coating resumes its intended function. This mechanism allows the formulation to deliver the API at a predefined location or rate within the gastrointestinal tract.

The invention offers particular advantages for drugs that require modified release, intestinal targeting, or protection from acidic gastric conditions. In addition, the technology supports the development of patient-friendly liquid formulations. This feature benefits pediatric, geriatric, and dysphagic patients who often struggle to swallow tablets or capsules. Overall, the patent combines the flexibility of pellet-based drug delivery with improved stability in aqueous dosage forms. Therefore, it represents an important advancement in oral pharmaceutical technology.

Impact of MCC spheres in this Patent

In EP3117824A1, CELLETS® or similar spherical starter cores serve as the fundamental substrate for producing the multilayered pharmaceutically active compound-releasing microparticles. These inert pellet cores, commonly composed of microcrystalline cellulose, provide a highly uniform and mechanically stable surface onto which drug-containing layers and subsequent functional coatings can be applied with high precision.

Their excellent sphericity promotes uniform coating thickness, which is critical for achieving reproducible controlled-release performance and minimizing variability between pellets. Furthermore, Cellets enable high drug loading while maintaining robust processing characteristics during fluid-bed coating operations.

Pellet size also plays an important role in the final product performance. Smaller pellets, typically in the range of 100–500 µm (such as CELLETS® 100, 200, 350), offer a larger surface area and can provide faster or more uniform drug release, whereas larger pellets, often between 500–1500 µm (such as CELLETS® 500, 700, 1000), facilitate the application of multiple coating layers and may support more sophisticated release profiles.

In addition, smaller pellets generally improve content uniformity and patient acceptability, especially in liquid and effervescent dosage forms, because they create a smoother mouthfeel and more homogeneous suspension. Therefore, selecting the appropriate Cellet size represents a key formulation parameter that influences coating efficiency, drug release kinetics, stability, and overall patient experience.

Acetylsalicylic Acid, Paracetamol, and Ascorbic Acid in Pellet-Based Effervescent Formulations

Although EP3117824A1 does not specifically focus on acetylsalicylic acid, paracetamol, or ascorbic acid, the technology applies well to these APIs. Acetylsalicylic acid, commonly known as aspirin, belongs to the nonsteroidal anti-inflammatory drug (NSAID) class. It treats pain, fever, inflammation, and cardiovascular disorders. Depending on the classification source and physiological conditions, aspirin generally falls within BCS Class I or Class III. Because aspirin can irritate the gastric mucosa, pellet-based controlled-release systems may improve gastrointestinal tolerability.

Paracetamol is an analgesic and antipyretic agent that treats pain and fever. It is generally classified as a BCS Class I compound due to its high solubility and permeability. Furthermore, pellet technology can improve taste masking and provide modified-release options. These properties make paracetamol formulations more suitable for pediatric and elderly patients.

Ascorbic acid, also known as vitamin C, functions as a water-soluble vitamin and antioxidant. Healthcare professionals use it to prevent and treat vitamin C deficiency. It exhibits high aqueous solubility and frequently appears in effervescent products. Moreover, pelletization can improve formulation stability by separating ascorbic acid from reactive ingredients. This approach may reduce degradation during storage and improve product quality.

Conclusion and Outlook

Multilayered pharmaceutically active compound technology offers a sophisticated solution for modern oral drug delivery. It combines coated pellet systems with liquid dosage forms while maintaining controlled-release functionality. Moreover, the technology supports improved stability, enhanced patient convenience, and flexible formulation design. When formulators incorporate pellets into effervescent tablets, they can protect sensitive APIs, reduce gastrointestinal side effects, and optimize therapeutic performance. As pharmaceutical research advances, multilayered pharmaceutically active compound systems will likely support more complex formulations and personalized treatment strategies. Consequently, this technology may become an increasingly important platform for next-generation oral medicines.

Patent Summary

  • Name of Patent: Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
  • Patent Number: EP3117824A1
  • Year of Patent: 2015
  • Patent Holders: Federica Ronchi, Jonathan Goole, Karim Amighi, Georges Guillaume, Vincent Stephenne
  • Affiliation: Be Pharbel Manufacturing
Cellets list of publication

Research Advances in MCC Pellet Technology and Applications

Scientific literature on MCC pellets highlights the growing importance of CELLETS® in pharmaceutical and scientific research. These microcrystalline cellulose spheres play a key role in developing reliable multiparticulate drug delivery systems. Researchers have investigated improved rivaroxaban dissolution, efficient film coating kinetics, and their use in orally disintegrating films. In addition, studies focus on colon-targeted vitamin B₂ release and fluidized-bed coating performance. Moreover, academic theses explore uniform hot-melt coating techniques and detailed modeling of tablet disintegration. As a result, MCC pellets continue to prove their versatility across many dosage forms. Consequently, this expanding body of literature reinforces the value of CELLETS® in advancing modern drug delivery technologies.

Selected Scientific literature on MCC pellets

Please, find scientific literature on MCC pellets (CELLETS®), MCC spheres. This list is constantly updated and does not claim to be complete. If you are author, scientist or R&D specialist, please submit your present publication to us for improving the visibility.

List – Publications with MCC spheres, 2026

Research article
High-Potency Pellet Microdosing Technology: A smart and easy way for production of low-dose active-ingredient capsules.
Tech4Pharma, 16(2), 2026, 58
A. Grave, E. Sternberger-Rützel

Research article
Formulation and Functional Characterization of a Novel Co-Processed Excipient for Direct Compression: Evaluation by the SeDeM Expert System
Preprint; doi: 10.20944/preprints202604.0109.v1
A. Ciurba, P. Antonoaea, E.-M. Rédai, A. Pintea, C. Pintea, A.-A. Cojocariu, M. Bîrsan, M.-F. Mihalcea, R.-A. Vlad

Research article
Challenges in the Oral Administration of Gastro-Resistant Formulations: The Role of Vehicles and Bottled Waters
Pharmaceutics 2026, 18(4), 453; doi: 10.3390/pharmaceutics18040453
A.K. Demeter, D. Farkas, M. Király, Á.T. Barna, K. Ludányi, I. Antal, N. Kállai-Szabó

Poster
Investigation of Pellet Agglomeration in Fluidised Bed Coating Processes: Influences of Size, Material, and Dispersion
Poster contribution, 2026
R. Jurek; M. Lachmann; E. Kempnich; K. Köhler

Research article
Pharmaceutical development of composition of effervescent tablets with acetylsalicylic acid, paracetamol, and ascorbic acid
Pharmaceutical Science Advances 4 (2026) 100123. doi: 10.1016/j.pscia.2026.100123
O. Panysheva

Research article
Enhancement of the Solubility and Dissolution Profile of Rivaroxaban by the Antisolvent Precipitation Technique: A Promising Approach
Polymers 2026, 18(9), 1134; doi: 10.3390/polym18091134
C. M. Benga, E. A. Ozon, A. M. Musuc, V. Anuța, I. Sârbu, V.-A. Surdu, F. Teodorescu, A. Rusu, L. Popa, M. V. Ghica, A. Chandak, C. E. D. Pîrvu

Research article
Modelling of Rheological Properties of Pharmaceutical Powder Mixtures for Direct Compression: A Statistical Approach
PharmSciTech 27, 121 (2026). doi: https://doi.org/10.1208/s12249-026-03359-w
P. Komínová, M. Gajdošová, D. Smrčka, P. Zámostný

Book
Pediatric Formulations – Micropellets: A Modern Multiparticulate Technology Platform for Pediatric Medicines | Springer Nature Link
Springer Cham (17 February 2026), ISBN 978-3-031-77239-9
H. Batchelor, K. Rose (Editors)

Book
GLATT-Wirbelschichttechnologie zum Coating von Pulvern, Pellets und Mikropellets
Springer-Verlag GmbH (02 January 2026), ISBN 978-3-662-71411-9 (print), 978-3-662-71412-6 (online); doi: 10.1007/978-3-662-71412-6_4
Annette Grave & Norbert Pöllinger

List – Publications with MCC spheres, 2025

Research article
Sustainable nanoarchitectonics of cellulose-derived spherical activated carbon for efficient uremic toxin removal in pharmaceutical applications
Materials & Design 259 (2025) 114892. doi: 10.1016/j.matdes.2025.114892
K. Shin, S.-B. Kim, Y.-H. Kim, D.-D. Kim, S.-Y. Lee, S.-J. Park

Research article
The Development and Characterization of Layered Pellets Containing a Combination of Amorphized Amlodipine Besylate and Hydrochlorothiazide Using a High-Shear Granulator
Pharmaceuticals 2025, 18(10), 1496. doi: 10.3390/ph18101496
A. A. K. Mahmoud, K. Ludasi, D. G. Dobó, D. Sebők, Á. Kukovecz, V. Hornok, K. Sajdik, T. Szabó, T. Sovány, G. Regdon, K. Kristó

Research article
Ultrasound Imaging of Artificial Tongues During Compression and Shearing of Food Gels on a Biomimetic Testing Bench
Journal of Texture Studies (2025) 56:e70030. doi: 10.1111/jtxs.70030
M. Glumac, J.-L. Gennisson, V. Mathieu

Research article
In vitro validation of colon delivery of vitamin B2 through a food grade multi-unit particle system
International Journal of Pharmaceutics (2025), 675, 125546. doi: 10.1016/j.ijpharm.2025.125546
M. Wolfgang, J. Poms, V. Herndler, I. Huegel, T. Kipping, M. Spoerk, J.G. Khinast

List – Publications with MCC spheres, 2024

Research article
In vitro validation of colon delivery of vitamin B2 through a food grade multi-unit particle system
Wageningen Academic (2024), eISSN: 1876-2891; doi:10.1163/18762891-bja00045
R.E. Steinert, W. Sybesma, R. Duss, A. Rehman, M. Watson, T.C. van den Ende, E. Funda

Research article
Homogeneity and mechanical properties of orodispersible films loaded with pellets
Eur. J. Pharm. Biopharm. 2024, 114537; doi:10.1016/j.ejpb.2024.114537
K. Centkowska, M. Szadkowska, M. Basztura, M. Sznitowska

Patent
Extended-release compositions comprising atomoxetine
A1

Patent
Extended release compositions comprising pyridostigmine
A1

Research article
Influence of Polymer Film Thickness on Drug Release from Fluidized Bed Coated Pellets and Intended Process and Product Control
Pharmaceutics 2024, 16(10), 1307; https://doi.org/10.3390/pharmaceutics16101307
M. Langner, F. Priese, and B. Wolf

Thesis
Characterization of dense granular flows using a continuous chute flow rheometer
Purdue University, School of Materials Engineering, West Lafayette, Indiana, posted on 2024-07-20, 03:12
Kayli Lynn Henry

Research article
The Increase in the Plasticity of Microcrystalline Cellulose Spheres’ When Loaded with a Plasticizer
Pharmaceutics (2024), 16(7), 945; doi: 10.3390/pharmaceutics16070945
A. Paulausks, T. Kolisnyk, V. Mohylyuk

Research article
The development of an innovative method to improve the dissolution performance of rivaroxaban
Heliyon 10(12), 2024, e33162; doi: 10.1016/j.heliyon.2024.e33162
E.A. Ozon, E. Mati, O. Karampelas, V. Anuta, I. Sarbu, A.M. Musuc, R.-A. Mitran, D.C. Culita, I. Atkinson, M. Anastasescu, D. Lupuliasa, M.A. Mitu

Thesis
Uniform and homogenous hot-melt coating in a Wurster fluidized bed
TUM School of Life Sciences der Technischen Universität München, 2024
B. M. Wörthmann

Thesis
Modelling the disintegration of pharmaceutical tablets: integrating a single particle swelling model with the discrete element method
University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, CMAC National Facility, 2024, Thesis identifier T16863
M. Soundaranathan

List – Publications with MCC spheres, 2023

Research article
Paediatric solid oral dosage forms for combination products: Improving in vitro swallowability of minitablets using binary mixtures with pellets
European Journal of Pharmaceutical Sciences (2023), 187, 106471; doi:10.1016/j.ejps.2023.106471
A. Avila-Sierra, A. Lavoisier, C. Timpe, P. Kuehl, L. Wagner, C. Tournier, M. Ramaioli

Research article
Continuous Manufacturing of Cocrystals Using 3D-Printed Microfluidic Chips Coupled with Spray Coating
Pharmaceuticals (2023), 16(8), 1064; doi:10.3390/ph16081064
A. Kara, D. Kumar 2, A.M. Healy, A. Lalatsa, and D.R. Serrano

Research article
High-Speed Tableting of High Drug-Loaded Tablets Prepared from Fluid-Bed Granulated Isoniazid
Pharmaceuticals (2023), 15(4), 1236; doi:10.3390/pharmaceutics15041236
V. Mohylyuk, and D. Bandere

Research article
The Effect of Design and Size of the Fluid‑Bed Equipment on the Particle Size‑Dependent Trend of Particle Coating Thickness and Drug Prolonged‑Release Profile
AAPS PharmSciTech (2023) 24, 93. doi:10.1208/s12249-023-02540-9
T. Brezovar, G. Hudovornik, M. Perpar, M. Luštrik, R. Dreu

Research article
Amorphous Solid Dispersions Layered onto Pellets—An Alternative to Spray Drying?
Pharmaceutics (2023) 15(3), 764. doi:10.3390/pharmaceutics15030764
M. Neuwirth, S.K. Kappes, M.U. Hartig, K.G. Wagner

Research article
Optimization of Fluidized-Bed Process Parameters for Coating Uniformity and Nutrient-Release Characteristics of Controlled-Release Urea Produced by Modified Lignocellulosic Coating Material
Agronomy (2023) 13(3), 725. doi:10.3390/agronomy13030725
A.M. Ali, B. Azeem, A.M. Alghamdi, K. Shahzad, A. Ahmad Al-Zahrani, M. Imtiaz Rashid, A. Binti Mahpudz, A. Jamil

Research article
Hydrodynamic behaviour of CELLETS® (Ph.Eur./USP) in a spouted bed using image processing method
Particuology (2023), 76, 101-112, doi:10.1016/j.partic.2022.07.009
J. Vanamu, A. Sahoo

Thesis
Oral delivery of microbiome-modulating synbiotics derived from kefir via alginate encapsulation systems
School of Materials Science and Engineering (2023); doi: 10.32657/10356/164624
L.L. Tan

List – Publications with MCC spheres, 2022

Research article
Review on Starter Pellets: Inert and Functional Cores
Pharmaceutics 2022, 14(6), 1299; doi: 10.3390/pharmaceutics14061299
N. Kállai-Szabó, M. Lengyel, D. Farkas, Á. T. Barna, C. Fleck, B. Basa, and I. Antal

Research article
Product-Property Guided Scale-Up of a Fluidized Bed Spray Granulation Process Using the CFD-DEM Method
Processes (2022) 10(7), 1291. doi:10.3390/pr10071291
P. Kieckhefen, S. Pietsch-Braune, S. Heinrich

Research article
Influence of In Situ Calcium Pectinate Coating on Metoprolol Tartrate Pellets for Controlled Release and Colon-Specific Drug Delivery
Pharmaceutics (2022) 14(5), 1061. doi: 10.3390/pharmaceutics14051061
P. Wanasawas, A. Mitrevej, N. Sinchaipanid

Research article
Delamination and wetting behavior of natural hot-melt coating materials
Powder Technology (2022) 404, 117443. doi: 10.1016/j.powtec.2022.117443
B.M. Woerthmann, L. Totzauer, H. Briesen

Research article
A systematic approach for assessing the suitability of enteral feeding tubes for the administration of controlled-release pellet formulations
International Journal of Pharmaceutics (2022) 612, 121286. doi: 10.1016/j.ijpharm.2021.121286
F. Karkossa, N. Lehmann, S. Klein

Research article
Spray-freeze-dried lyospheres: Solid content and the impact on flowability and mechanical stability
Powder Technology (2022) 411, 117905. doi:10.1016/j.powtec.2022.117905
A. Rautenberg, A. Lamprecht

Conference proceedings
Assessment of the effect of microcrystalline cellulose (MCC) spheres size on the flow via powder rheology
The FORGE, 2022 – pure.qub.ac.uk; doi: 10.13140/RG.2.2.14935.75688
V. Mohylyuk, R. Dattani

Research article
Solventless amorphization and pelletization using a high shear granulator. Part II; Preparation of co-amorphous mixture-layered pellets using indomethacin and arginine
European Journal of Pharmaceutics and Biopharmaceutics (2022) 181, 183-194. doi: 10.1016/j.ejpb.2022.11.011
K. Kondo, T. Rades

Research article
Solventless amorphization and pelletization using a high shear granulator. Part I; feasibility study using indomethacin
European Journal of Pharmaceutics and Biopharmaceutics (2022) 181, 147-158. doi: 10.1016/j.ejpb.2022.11.010
K. Kondo, T. Rades

Research article
Application of different models to evaluate the key factors of fluidized bed layering granulation and their influence on granule characteristics
Powder Technology (2022), 408:117737. doi: 10.1016/j.powtec.2022.117737
R. Maharjan, S. H. Jeong

Research article
Evaluation of gravitational consolidation of binary powder mixtures by modified Heckel equation
Powder Technology (2022), 408:117729. doi: 10.1016/j.powtec.2022.117729
P. Svačinová, O. Macho, Ž. Jarolímová, M. Kuentz, Ľ. Gabrišová and Z. Šklubalová

Research article
Integrated Purification and Formulation of an Active Pharmaceutical Ingredient via Agitated Bed Crystallization and Fluidized Bed Processing
Pharmaceutics (2022), 14(5)1058. doi: 10.3390/pharmaceutics14051058
M. W. Stocker, M. J. Harding, V. Todaro, A. M. Healy and S. Ferguson

List – Publications with MCC spheres, 2021

Research article
Correlating Granule Surface Structure Morphology and Process Conditions in Fluidized Bed Layering Spray Granulation
KONA Powder and Particle Journal (2021), DOI:10.14356/kona.2022016
M. Orth, P. Kieckhefen, S. Pietsch and S. Heinrich

Research article
Relative bioavailability enhancement of simvastatin via dry emulsion systems: comparison of spray drying and fluid bed layering technology
Eur J Pharm Biopharm (2021), S0939-6411(21)00353-2. doi: 10.1016/j.ejpb.2021.12.004
M. Pohlen, J. Aguiar Zdovc, J. Trontelj, J. Mravljak, M. G. Matjaž, I. Grabnar, T. Snoj and R. Dreu

Research article
A novel method for assessing the coating uniformity of hot-melt coated particles using micro-computed tomography
Powder Technology, Volume 378, Part A, 22 January 2021, Pages 51-59
B.M. Woerthmann, J.A. Lindner, T. Kovacevic, P. Pergam, F. Schmid, H. Briesen

List – Publications with MCC spheres, 2020

Research article
Fixed-bed-column studies for methylene blue removal by cellulose CELLETS
Environmental Engineering and Management Journal 19 (2020), 2, 269-279
Iulia Nica, Gabriela Biliuta, Carmen Zaharia, Lacramioara Rusu, Sergiu Coseri, Daniela Suteu

Research article
Material specific drying kinetics in fluidized bed drying under mechanical vibration using the reaction engineering approach
Advanced Powder Technology, Volume 31, Issue 12, December 2020, Pages 4699-4713
Soeren E. Lehmann, Tobias Oesau, Alfred Jongsma, Fredrik Innings, Stefan Heinrich

Research article
Simulation of pellet coating in Wurster coaters
International Journal of Pharmaceutics, Volume 590, 30 November 2020, 119931
Hamid Reza Norouzi

Research article
Quantification of swelling characteristics of pharmaceutical particles
International Journal of Pharmaceutics, Volume 590, 30 November 2020, 119903
Mithushan Soundaranathan, Pattavet Vivattanaseth, Erin Walsh, Kendal Pitt, Blair Johnston, Daniel Markl

Short communication
Introduction of the energy to break an avalanche as a promising parameter for powder flowability prediction
Powder Technology, Volume 375, 20 September 2020, Pages 33-41
Žofie Trpělková, Hana Hurychová, Martin Kuentz, Barbora Vraníková, Zdenka Šklubalová

Research article
Easy to Swallow “Instant” Jelly Formulations for Sustained Release Gliclazide Delivery
Journal of Pharmaceutical Sciences, Volume 109, Issue 8, August 2020, Pages 2474-2484
Simmi Patel, Nathan Scott, Kavil Patel, Valentyn Mohylyuk, William J. McAuley, Fang Liu

Research article
Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles
International Journal of Pharmaceutics, Volume 585, 30 July 2020, 119562
Nathan Scott, Kavil Patel, Tariro Sithole, Konstantina Xenofontos, Valentyn Mohylyuk, Fang Liu

Research article
Measuring segregation characteristics of industrially relevant granular mixtures: Part II – Experimental application and validation
Powder Technology, Volume 368, 15 May 2020, Pages 278-285
Alexander M. Fry, Vidya Vidyapati, John P. Hecht, Paul B. Umbanhowar, Julio M. Ottinoa, Richard M. Lueptow

Research article
Non-uniform drug distribution matrix system (NUDDMat) for zero-order release of drugs with different solubility
International Journal of Pharmaceutics, Volume 581, 15 May 2020, 119217
Matteo Cerea, Anastasia Foppoli, Luca Palugan, Alic Melocchi, Lucia Zema, Alessandra Maroni, Andrea Gazzaniga

Research article
Effects of humidity on cellulose pellets loaded with potassium titanium oxide oxalate for detection of hydrogen peroxide vapor in powders
Powder Technology, Volume 366, 15 April 2020, Pages 348-357
Maria H. Kastvig, Cosima Hirschberg, Frans W.J. Van Den Berg, Jukka Rantanen, Mogens L. Andersen

Research article
In-line particle size measurement and process influences on rotary fluidized bed agglomeration
Powder Technology, Volume 364, 15 March 2020, Pages 673-679
Marcel Langner, Ivonne Kitzmann, Anna-Lena Ruppert, Inken Wittich, Bertram Wolf

Research article
Recent advance in delivery system and tissue engineering applications of chondroitin sulfate
Carbohydrate Polymers, Volume 230, 15 February 2020, 115650
Jun Yang, Mingyue Shen, Huiliang Wen, Yu Luo, Rong Huang, Liyuan Rong, Jianhua Xie

Research article
Fixed-bed-column studies for Methylene blue removal by Cellulose CELLETS
Environmental Engineering and Management Journal, Volume 19 (2), March 2020, 269-279
Iulia Nica, Gabriela Biliuta, Carmen Zaharia, Lacramioara Rusu, Sergiu Coseri, Daniela Suteu

Research article
Optimization and tracking of coating processes of pellets with polyvinylpyrrolidone solutions in an acoustic levitator
Powder Technology, Volume 360, 15 January 2020, Pages 1126-1133
Doris L. Wong, Anna-Lena Wirsching, Kai Betz, Andreas Reinbeck, Hans-Ulrich Moritz, Werner Pauer

List – Publications with MCC spheres, 2019

Research article
A regenerable microporous adsorbent based on microcrystalline cellulose for organic pollutants adsorption
Desalination and Water Treatment Volume 146, April 2019, Pages 176-187
Daniela Suteu, Gabriela Biliuta, Lacramioara Rusu, Sergiu Coseri, Christophe Vial, Iulia Nica (Nebunu)

Research article
Measurement of hydrogen peroxide vapor in powders with potassium titanium oxide oxalate loaded cellulose pellets as probes
AAPS PharmSciTech, Volume 21(1):3, 11 Nov 2019
Maria H. Kastvig, Johan P. Bøtker, Ge Ge, Mogens L. Andersen

Research article
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production of Oral Sustained-Release Liquid Medicines for Patients with Swallowing Difficulties
AAPS PharmSciTech, Volume 21(1):3, 11 Nov 2019
Valentyn Mohylyuk, Kavil Patel, Nathan Scott, Craig Richardson, Darragh Murnane, Fang Liu

Research article
Assessment of the effect of Cellets’ particle size on the flow in a Wurster fluid-bed coater via powder rheology
Journal of Drug Delivery Science and Technology, 54, December 2019, 101320; doi: 10.1016/j.jddst.2019.101320
Valentyn Mohylyuk, Ioanna Danai Styliari, Dmytryi Novykov, Reiss Pikett, Rajeev Dattani

Research article
Particle electrification in an apparatus with a draft tube operating in a fast circulating dilute spout-fluid bed regime
Particuology, Volume 42, February 2019, Pages 146-153
Wojciech Ludwig

Research article
Development and evaluation of budesonide-based modified-release liquid oral dosage forms
Journal of Drug Delivery Science and Technology, Volume 54, December 2019, 101273
Federica Ronchi, Antonio Sereno, Maxime Paide, Ismaël Hennia, Pierre Sacré, George Guillaume, Vincent Stéphenne, Jonathan Goole, Karim Amighi

Research article
Evaluation of in-line particle measurement with an SFT-probe as monitoring tool for process automation using a new time-based buffer approach
European Journal of Pharmaceutical Sciences, Volume 128, 1 February 2019, Pages 162-170
Theresa Reimers, Jochen Thies, Stefan Dietrich, Julian Quodbach, Miriam Pein-Hackelbusch

Research article
In vitro and sensory tests to design easy-to-swallow multi-particulate formulations
European Journal of Pharmaceutical Sciences, Volume 132, 30 April 2019, Pages 157-162
Marco Marconati, Felipe Lopez, Catherine Tuleu, Mine Orlu, Marco Ramaioli

Research article
Numerical study of the hydrodynamics of fluidized beds operated under sub-atmospheric pressure
Chemical Engineering Journal, Volume 372, 15 September 2019, Pages 1134-1153
Sayali Zarekar, Andreas Bück, Michael Jacob, Evangelos Tsotsas

Research article
Solidification of carvedilol loaded SMEDDS by swirling fluidized bed pellet coating
International Journal of Pharmaceutics, Volume 566, 20 July 2019, Pages 89-100
J. Mandić, M. Luštrik, F. Vrečer, M. Gašperlin, A. Zvonar Pobirk

Research article
Quantitative bin flow analysis of particle discharge using X-ray radiography
Powder Technology, Volume 344, 15 February 2019, Pages 693-705
Sanket Bacchuwar, Vidya Vidyapati, Ke-ming Quan, Chen-Luh Lin, Jan D. Miller

Research article
Adjustment of triple shellac coating for precise release of bioactive substances with different physico-chemical properties in the ileocolonic region
International Journal of Pharmaceutics, Volume 564, 10 June 2019, Pages 472-484>
Eva-Maria Theismann, Julia Katharina Keppler, Jörg-Rainer Knipp, Daniela Fangmann, Esther Appel, Stanislav N. Gorb, Georg H. Waetzig, Stefan Schreiber, Matthias Laudes, Karin Schwarz

Research article
The analysis of the influence of the normal restitution coefficient model on calculated particles velocities by means of Eulerian-Lagrangian approach
Powder Technology, Volume 344, 15 February 2019, Pages 140-151
Wojciech Ludwig, PaweƚPłuszka

Research article
Measurement of granule layer thickness in a spouted bed coating process via optical coherence tomography
Powder Technology, Volume 356, November 2019, Pages 139-147
Swantje Pietsch, Anna Peter, Patrick Wahl, Johannes Khinast, Stefan Heinrich

Research article
A novel method of quantifying the coating progress in a three-dimensional prismatic spouted bed
Particuology, Volume 42, February 2019, Pages 137-145
Swantje Pietsch, Finn Ole Poppinga, Stefan Heinrich, Michael Müller, Michael Schönherr, Frank Kleine Jäger

Research article
Development and evaluation of an omeprazole-based delayed-release liquid oral dosage form
International Journal of Pharmaceutics, Volume 567, 15 August 2019, 118416
Federica Ronchi, Antonio, Sereno, Maxime Paide, Pierre Sacré, George Guillaume, Vincent Stéphenne, Jonathan Goole, Karim Amighi

Research article
Influence of separation properties and processing strategies on product characteristics in continuous fluidized bed spray granulation
Powder Technology, Volume 342, 15 January 2019, Pages 572-584
Daniel Müller, Andreas Bück, Evangelos Tsotsas

List – Publications with MCC spheres, 2018

Short communication
Novel production method of tracer particles for residence time measurements in gas-solid processes
Powder Technology, Volume 338, October 2018, Pages 1-6
Swantje Pietsch, Paul Kieckhefen, Michael Müller, Michael Schönherr, Frank Kleine Jäger, Stefan Heinrich

Research article
The effect of administration media on palatability and ease of swallowing of multiparticulate formulations
International Journal of Pharmaceutics, Volume 551, Issues 1–2, 15 November 2018, Pages 67-75
Felipe L. Lopez, Terry B. Ernest, Mine Orlu, CatherineTuleu

Research article
Exploring a Modern Control Strategy for Wurster Coating
Pharmaceutical Technology, 2018, 43(8), 453
E. Godek, C. O’Callaghan, I. Jones, P. Patel

Research article
Compressibility and tablet forming ability of bimodal granule mixtures: Experiments and DEM simulations
International Journal of Pharmaceutics, Volume 540, Issues 1–2, 5 April 2018, Pages 120-131
Josefina Nordström, Göran Alderborn, Göran Frenning

Research article
Effects of pharmaceutical processes on the quality of ethylcellulose coated pellets: Quality by design approach
Powder Technology, Volume 339, November 2018, Pages 25-38
Prakash Thapa, Ritu Thapa, Du Hyung Choi, Seong Hoon Jeong

Research article
Euler-Lagrange model of particles circulation in a spout-fluid bed apparatus for dry coating
Powder Technology, Volume 328, 1 April 2018, Pages 375-388
Wojciech Ludwig, Paweł Płuszka

Research article
Inline acoustic monitoring to determine fluidized bed performance during pharmaceutical coating
International Journal of Pharmaceutics, Volume 549, Issues 1–2, 5 October 2018, Pages 293-298
Allan Carter, Lauren Briens

Research article
Sifting segregation of ideal blends in a two-hopper tester: Segregation profiles and segregation magnitudes
Powder Technology, Volume 331, 15 May 2018, Pages 60-67
Mariagrazia Marucci, Banien Al-Saaigh, Catherine Boissier, Marie Wahlgren, Håkan Wikström

Conference abstract
Multiple unit mini-tablets: Content uniformity issues
International Journal of Pharmaceutics, Volume 536, Issue 2, 5 February 2018, Pages 506-507
Anna Kira Adam, Jörg Breitkreutz

Research article
Influence of gas inflow modelling on CFD-DEM simulations of three-dimensional prismatic spouted beds
Powder Technology, Volume 329, 15 April 2018, Pages 167-180
Paul Kieckhefen, Swantje Pietsch, Moritz Höfert, Michael Schönherr, Stefan Heinrich, Frank Kleine Jäger

Research article
A redispersible dry emulsion system with simvastatin prepared via fluid bed layering as a means of dissolution enhancement of a lipophilic drug
International Journal of Pharmaceutics, Volume 549, Issues 1–2, 5 October 2018, Pages 325-334
Mitja Pohlen, Luka Pirker, Matevž Luštrik, Rok Dreu

Review article
Overview of PAT process analysers applicable in monitoring of film coating unit operations for manufacturing of solid oral dosage forms
European Journal of Pharmaceutical Sciences, Volume 111, 1 January 2018, Pages 278-292
Klemen Korasa, Franc Vrečer

Research article
On the properties and application of beeswax, carnauba wax and palm fat mixtures for hot melt coating in fluidized beds
Advanced Powder Technology, Volume 29, Issue 3, March 2018, Pages 781-788
M.G. Müller, J.A. Lindner, H. Briesen, K. Sommer, P. Foerst

Research article
Novel hydrophilic matrix system with non-uniform drug distribution for zero-order release kinetics
Journal of Controlled Release, Volume 287, 10 October 2018, Pages 247-256
Matteo Cerea, Alessandra Maroni, Luca Palugan, Marco Bellini, Anastasia Foppoli, Alice Melocchi, Lucia Zema, Andrea Gazzaniga

Research article
Role of plasticizer in membrane coated extended release oral drug delivery system
Journal of Drug Delivery Science and Technology, Volume 44, April 2018, Pages 231-243
Pinak Khatri, Dipen Desai, Namdev Shelke, Tamara Minko

Research article
Evaluation of pellet cycle times in a Wurster chamber using a photoluminescence method
Chemical Engineering Research and Design, Volume 132, April 2018, Pages 1170-1179
Domen Kitak, Rok Šibanc, Rok Dreu

Research article
Influence of perforated draft tube air intake on a pellet coating process
Powder Technology, Volume 330, 1 May 2018, Pages 114-124
Matevž Luštrik, Rok Dreu, Matjaž Perpar

Research article
Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating
European Journal of Pharmaceutics and Biopharmaceutics, Volume 124, March 2018, Pages 13-27
Dolores R. Serrano, David Walsh, Peter O’Connell, Naila A. Mugheirbi, Zelalem Ayenew Worku, Francisco Bolas-Fernandez, Carolina Galiana, Maria Auxiliadora Dea-Ayuela, Anne Marie Healy


Research article

Research article
Mechanics of Pharmaceutical Pellets—Constitutive Properties, Deformation, and Breakage Behavior
Journal of Pharmaceutical Sciences, Volume 107, Issue 2, February 2018, Pages 571-586
Alexander Russell, Rok Šibanc, Rok Dreu, Peter Müller

List – Publications with MCC spheres, 2017

Research article
Production of composite particles using an innovative continuous dry coating process derived from extrusion
Advanced Powder Technology, Volume 28, Issue 11, November 2017, Pages 2875-2885
Fanny Cavaillès, Romain Sescousse, Alain Chamayou, Laurence Galet

Research article
Determination of the release mechanism of Theophylline from pellets coated with Surelease®—A water dispersion of ethyl cellulose
International Journal of Pharmaceutics, Volume 528, Issues 1–2, 7 August 2017, Pages 345-353
Jurgita Kazlauske, Maria Margherita Cafaro, Diego Caccavo, Mariagrazia Marucci, Gaetano Lamberti, Anna Angela Barba, Anette Larsson

Research article
In-line monitoring of multi-layered film-coating on pellets using Raman spectroscopy by MCR and PLS analyses
European Journal of Pharmaceutics and Biopharmaceutics, Volume 114, May 2017, Pages 194-201
Jin Hisazumi, Peter Kleinebudde

Research article
Analysis of pellet coating uniformity using a computer scanner
International Journal of Pharmaceutics, Volume 533, Issue 2, 30 November 2017, Pages 377-382
Rok Šibanc, Matevž Luštrik, Rok Dreu

Research article
Modeling of particle velocities in an apparatus with a draft tube operating in a fast circulating dilute spout-fluid bed regime
Powder Technology, Volume 319, September 2017, Pages 332-345
Wojciech Ludwig, Daniel Zając

Research article
UV imaging of multiple unit pellet system (MUPS) tablets: A case study of acetylsalicylic acid stability
European Journal of Pharmaceutics and Biopharmaceutics, Volume 119, October 2017, Pages 447-453
Anna Novikova, Jens M. Carstensen, Thomas Rades, Claudia S. Leopold

Research article
Influence of Water on the Structure and Dielectric Properties of the Microcrystalline and Nano-Cellulose
Nanoscale Res Lett 12, 468 (2017); doi: 10.1186/s11671-017-2231-5
Kovalov, K.M., Alekseev, O.M., Lazarenko, M.M.

Research article
New hybrid CPU-GPU solver for CFD-DEM simulation of fluidized beds
Powder Technology, Volume 316, 1 July 2017, Pages 233-244
H.R. Norouzi, R. Zarghami, N. Mostoufi

Research article
A top coating strategy with highly bonding polymers to enable direct tableting of multiple unit pellet system (MUPS)
Powder Technology, Volume 305, January 2017, Pages 591-596
Frederick Osei-Yeboah, Yidan Lan, Changquan Calvin Sun

Research article
Synthesis and melt processing of cellulose esters for preparation of thermoforming materials and extended drug release tablets
Carbohydrate Polymers, Volume 177, 1 December 2017, Pages 105-115
Sanna Virtanen, Riku Talja, Sauli Vuoti

Research article
Downstream drug product processing of itraconazole nanosuspension: Factors influencing drug particle size and dissolution from nanosuspension-layered beads
International Journal of Pharmaceutics, Volume 524, Issues 1–2, 30 May 2017, Pages 443-453
Johannes Parmentier, En Hui Tan, Ariana Low, Jan Peter Möschwitzer

List – Publications with MCC spheres, 2016

Research article
In-line particle size measurement and agglomeration detection of pellet fluidized bed coating by Spatial Filter Velocimetry
Powder Technology, Volume 301, November 2016, Pages 261-267
Dimitri Wiegel, Günter Eckardt, Florian Priese, Bertram Wolf

Research article
Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers
European Journal of Pharmaceutical Sciences, Volume 92, 20 September 2016, Pages 156-162
Felipe L. Lopez, Alexandra Bowles, Mine Orlu Gul, David Clapham, Terry B. Ernest, Catherine Tuleu

Research article
Micropellet-loaded rods with dose-independent sustained release properties for individual dosing via the Solid Dosage Pen
International Journal of Pharmaceutics, Volume 499, Issues 1–2, 29 February 2016, Pages 271-279
Eva Julia Laukamp, Klaus Knop, Markus Thommes, Joerg Breitkreutz

Research article
Multivariate calibration of the degree of crystallinity in intact pellets by X-ray powder diffraction
International Journal of Pharmaceutics, Volume 502, Issues 1–2, 11 April 2016, Pages 107-116
Krisztina Nikowitz, Attila Domján, Klára Pintye-Hódi, Géza Regdon jr.

Research article
Towards improving quality of video-based vehicle counting method for traffic flow estimation
Signal Processing, Volume 120, March 2016, Pages 672-681
Yingjie Xia, Xingmin Shi, Guanghua Song, Qiaolei Geng, Yuncai Liu

Conference abstract
Multiple-unit orodispersible mini-tablets
International Journal of Pharmaceutics, Volume 511, Issue 2, 25 September 2016, Page 1128
Anna Kira Adam, Christian Zimmer, Stefan Rauscher, Jörg Breitkreutz

Research article
Asymmetric distribution in twin screw granulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 106, September 2016, Pages 50-58
Tim Chan Seem, Neil A. Rowson, Ian Gabbott, Marcelde Matas, Gavin K. Reynolds, AndyIngram

Research article
Measurement of particle concentration in a Wurster coater draft tube using light attenuation
Chemical Engineering Research and Design, Volume 110, June 2016, Pages 20-31
R. Šibanc, I. Žun, R. Dreu

List – Publications with MCC spheres, 2015

Research article
Two-dimensional particle shape analysis from chord measurements to increase accuracy of particle shape determination
Powder Technology, Volume 284, November 2015, Pages 25-31
D. Petrak, S. Dietrich, G. Eckardt, M. Köhler

Research article
Passive acoustic emission monitoring of pellet coat thickness in a fluidized bed
Powder Technology, Volume 286, December 2015, Pages 172-180
Taylor Sheahan, Lauren Briens

Research article
Tabletability Modulation Through Surface Engineering
Journal of Pharmaceutical Sciences, Volume 104, Issue 8, August 2015, Pages 2645-2648
Frederick Osei-Yeboah, Changquan Calvin Sun

Research article
Cellulose CELLETS as new type of adsorbent for the removal of dyes from aqueous media
Environmental Engineering and Management Journal, Volume 14, Issue 3, March 2015, Pages 525-532
Daniela Suteu, Gabriela Biliuta, Lacramioara Rusu, Sergiu Coseri, Gabriela Nacu

Research article
Formulation and process optimization of multiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane
International Journal of Pharmaceutics, Volume 480, Issues 1–2, 1 March 2015, Pages 15-26
Sheng-Feng Hung, Chien-Ming Hsieh, Ying-Chen Chen, Cheng-Mao Lin, Hsiu-O Ho, Ming-Thau Sheu

Research article
Dry Coating Characterization of Coverage by Image Analysis: Methodology
Procedia Engineering, Volume 102, 2015, Pages 81-88
Olivier Lecoq, Fredj Kaouach, Alain Chamayou

Research article
Passive acoustic emissions monitoring of the coating of pellets in a fluidized bed—A feasibility analysis
Powder Technology, Volume 283, October 2015, Pages 373-379
Taylor Sheahan, Lauren Briens

List – Publications with MCC spheres, 2014

Research article
A New Apparatus for Real‐Time Assessment of the Particle Size Distribution of Disintegrating Tablets
Journal of Pharmaceutical Sciences, Volume 103, Issue 11, November 2014, Pages 3657-3665
Julian Quodbach, Peter Kleinebudde

Research article
In-line spatial filtering velocimetry for particle size and film thickness determination in fluidized-bed pellet coating processes
European Journal of Pharmaceutics and Biopharmaceutics, Volume 88, Issue 3, November 2014, Pages 931-938
Friederike Folttmann, Klaus Knop, Peter Kleinebudde, Miriam Pein

Research article
On-line monitoring of fluid bed granulation by photometric imaging
European Journal of Pharmaceutics and Biopharmaceutics, Volume 88, Issue 3, November 2014, Pages 879-885
Ira Soppela, Osmo Antikainen, Niklas Sandler, Jouko Yliruusi

Research article
Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients
International Journal of Pharmaceutics
Volume 460, Issues 1–2, 2 January 2014, Pages 228-233

Anna Kluk, Malgorzata Sznitowska

Research article
In-line monitoring of pellet coating thickness growth by means of visual imaging
International Journal of Pharmaceutics, Volume 470, Issues 1–2, 15 August 2014, Pages 8-14
Nika Oman Kadunc, Rok Šibanc, Rok Dreu, Boštjan Likar, Dejan Tomaževič

Research article
Optical microscopy as a comparative analytical technique for single-particle dissolution studies
International Journal of Pharmaceutics, Volume 469, Issue 1, 20 July 2014, Pages 10-16
Sami Svanbäck, Henrik Ehlers, Jouko Yliruusi

Research article
Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs
European Journal of Pharmaceutics and Biopharmaceutics, Volume 87, Issue 1, May 2014, Pages 107-113
Lieselotte De Smet, Lien Saerens, Thomas De Beer, Robert Carleer, Peter Adriaensens, Jan Van Bocxlaer, Chris Vervaet, Jean PaulRemon

Research article
Global monitoring of fluidized-bed processes by means of microwave cavity resonances
Measurement, Volume 55, September 2014, Pages 520-535
Johan Nohlert, Livia Cerullo, Johan Winges, Thomas Rylander, Tomas McKelvey, Anders Holmgren, Lubomir Gradinarsky, Staffan Folestad, Mats Viberg, Anders Rasmuson

List – Publications with MCC spheres, 2013

Research article
Water-mediated solid-state transformation of a polymorphic drug during aqueous-based drug-layer coating of pellets
International Journal of Pharmaceutics, Volume 456, Issue 1, 1 November 2013, Pages 41-48
Andres Lust, Satu Lakio, Julia Vintsevits, Jekaterina Kozlova, Peep Veski, Jyrki Heinämäki, Karin Kogermann

Research article
Preparation and characterization of controlled-release doxazosin mesylate pellets using a simple drug layering-aquacoating technique
Journal of Pharmaceutical Investigation (2013), 43:333–342. doi: 10.1007/s40005-013-0077-0
H. A. Hazzah, M. A. EL-Massik, O. Y. Abdallah & H. Abdelkader

Research article
Development of high drug loaded pellets by Design of Experiment and population balance model calculation
Powder Technology, Volume 241, June 2013, Pages 149-157
Florian Priese, Bertram Wolf

Research article
Particle sizing measurements in pharmaceutical applications: Comparison of in-process methods versus off-line methods
European Journal of Pharmaceutics and Biopharmaceutics, Volume 85, Issue 3, Part B, November 2013, Pages 1006-1018
Ana F.T. Silva, Anneleen Burggraeve, Quenten Denon, Paul Van der Meeren, Niklas Sandler, Tom Van Den Kerkhof, Mario Hellings, Chris Vervaet, Jean Paul Remon, João Almeida Lopes, Thomas De Beer

Research article
Physical properties of pharmaceutical pellets
Chemical Engineering Science, Volume 86, 4 February 2013, Pages 50-60
Rok Šibanc, Teja Kitak, Biljana Govedarica, StankoSrčič Rok Dreu

Research article
Continuous pellet coating in a Wurster fluidized bed process
Chemical Engineering Science, Volume 86, 4 February 2013, Pages 87-98
N. Hampel, A. Bück, M. Peglow, E. Tsotsas

Research article
Study of the recrystallization in coated pellets – Effect of coating on API crystallinity
European Journal of Pharmaceutical Sciences, Volume 48, Issue 3, 14 February 2013, Pages 563-571
Krisztina Nikowitz, Klára Pintye-Hódi, Géza Regdon Jr.

Research article
The influence of rolling friction on the shear behaviour of non-cohesive pharmaceutical granules – An experimental and numerical investigation
European Journal of Pharmaceutical Sciences, Volume 49, Issue 2, 13 May 2013, Pages 241-250
Ann-Sofie Persson, Göran Frenning

Research article
Characteristics of pellet flow in a Wurster coater draft tube utilizing piezoelectric probe
Powder Technology, Volume 235, February 2013, Pages 640-651
Matevž Luštrik, Rok Šibanc, Stanko Srčič, Matjaž Perpar, Iztok Žun, Rok Dreu

Research article
Estimating coating quality parameters on the basis of pressure drop measurements in a Wurster draft tube
Powder Technology, Volume 246, September 2013, Pages 41-50
Matjaž Perpar, Matevž Luštrik, Rok Dreu, Stanko Srčič, Iztok Žun

Research article
Influence of Non-Water-Soluble Placebo Pellets of Different Sizes on the Characteristics of Orally Disintegrating Tablets Manufactured by Freeze-Drying
Journal of Pharmaceutical Sciences, Volume 102, Issue 6, June 2013, Pages 1786-1799
Ulrike Stange, Christian Führling, Henning Gieseler

List – Publications with MCC spheres, 2012

Research article
A density-based segmentation for 3D images, an application for X-ray micro-tomography
Analytica Chimica Acta, Volume 725, 6 May 2012, Pages 14-21
Thanh N. Tran, Thanh T. Nguyen, Tofan A. Willemsz, Gijsvan Kessel, Henderik W. Frijlink, Kees van der Voort Maarschalk

Research article
Attrition and abrasion resistance of particles coated with pre-mixed polymer coating systems
Powder Technology, Volume 230, November 2012, Pages 1-13
G. Perfetti, F. Depypere, S. Zafari, P. van Hee, W.J. Wildeboer, G. M. H. Meesters

Research article
New spout-fluid bed apparatus for electrostatic coating of fine particles and encapsulation
Powder Technology, Volume 225, July 2012, Pages 52-57
Roman G. Szafran, Wojciech Ludwig, Andrzej Kmiec

Research article
Particle size and packing characterization by diffuse light transmission
Particuology Volume 10, Issue 5, October 2012, Pages 619-627
Henrik Ehlers, Jyrki Heinämäki, Jouko Yliruusi

Research article
Dry Powder Coating in a Modified Wurster Apparatus
Procedia Engineering, Volume 42, 2012, Pages 437-446
W. Ludwig, R.G. Szafran, A. Kmiec, J. Dziak

Research article
Attrition strength of water-soluble cellulose derivative coatings applied on different core materials
Powder Technology, Volume 222, May 2012, Pages 71-79
Katarzyna Nienaltowska, Frédéric Depypere, Giacomo Perfetti, Gabrie M.H. Meesters, Frederik Ronsse, Jan G. Pieters, Koen Dewettinck

Research article
An experimental evaluation of the accuracy to simulate granule bed compression using the discrete element method
Powder Technology, Volume 219, March 2012, Pages 249-256
Ann-Sofie Persson, Göran Frenning

List – Publications with MCC spheres, 2011

Research article
Understanding Fluidized-Bed Granulation
Pharmaceutical Technology 35 (8), 2011, 63-67
A. Burggraeve, T. Van Den Kerkhof, M. Hellings, J.P. Remon, C. Vervaet, T. De Beer

Research article
Dry particle high coating of biopowders: An energy approach
Powder Technology, Volume 208, Issue 2, 25 March 2011, Pages 378-382
S. Otles, O. Lecoq, J. A. Dodds

Research article
A density based segmentation method to determine the coordination number of a particulate system
Chemical Engineering Science, Volume 66, Issue 24, 15 December 2011, Pages 6385-6392
Thanh T. Nguyen, Thanh N. Tran, Tofan A. Willemsz, Henderik W. Frijlink, Tuomas Ervasti, Jarkko Ketolainen, Kees van der Voort Maarschalk

Research article
Study of the preparation of a multiparticulate drug delivery system with a layering technique
Powder Technology, Volume 205, Issues 1–3, 10 January 2011, Pages 155-159
Krisztina Nikowitz, Péter Kása Jr., Klára Pintye-Hódi, Géza Regdon Jr.

Research article
Effect of annealing time and addition of lactose on release of a model substance from Eudragit® RS coated pellets produced by a fluidized bed coater
Chemical Engineering Research and Design, Volume 89, Issue 6, June 2011, Pages 697-705
Ulrich M. Heckötter, Anette Larsson, Pornsak Sriamornsak, Mont Kumpugdee-Vollrath

Research article
Suspension pellet layering using PVA–PEG graft copolymer as a new binder
International Journal of Pharmaceutics, Volume 412, Issues 1–2, 30 June 2011, Pages 28-36
L. Suhrenbrock, G. Radtke, K. Knop, P. Kleinebudde

Research article
In-line particle sizing for real-time process control by fibre-optical spatial filtering technique (SFT)
Advanced Powder Technology, Volume 22, Issue 2, March 2011, Pages 203-208
Petrak Dieter, Dietrich Stefan, Eckardt Günter, Köhler Michael

Research article
Flowability of surface modified pharmaceutical granules: A comparative experimental and numerical study
European Journal of Pharmaceutical Sciences, Volume 42, Issue 3, 14 February 2011, Pages 199-209
Ann-Sofie Persson, Göran Alderborn, Göran Frenning

List – Publications with MCC spheres, 2010

Research article
Labscale fluidized bed granulator instrumented with non-invasive process monitoring devices
Chemical Engineering Journal, Volume 164, Issues 2–3, 1 November 2010, Pages 268-274
Jari T. T. Leskinen, Matti-Antero H. Okkonen, Maunu M. Toiviainen, Sami Poutiainen, Mari Tenhunen, Pekka Teppola, Reijo Lappalainen, Jarkko Ketolainen, Kristiina Järvinen

Research article
X-ray micro tomography and image analysis as complementary methods for morphological characterization and coating thickness measurement of coated particles
Advanced Powder Technology, Volume 21, Issue 6, November 2010, Pages 663-675
Giacomo Perfetti, Elke Van de Casteele, Bernd Rieger, Willem J. Wildeboer, Gabrie M.H. Meesters

Research article
New insights into segregation during tabletting
International Journal of Pharmaceutics, Volume 397, Issues 1–2, 15 September 2010, Pages 19-26
S. Lakio, S. Siiriä, H. Räikkönen, S. Airaksinen, T. Närvänen, O. Antikainen, J.Yliruusi

Research article
Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 76, Issue 1, September 2010, Pages 138-146
A. Burggraeve, T. Van Den Kerkhof, M. Hellings, J.P. Remon, C. Vervaet, T. De Beera

Research article
Granule size distribution of tablets
Journal of Pharmaceutical Sciences, Volume 99, Issue 4, April 2010, Pages 2061-2069
Satu Virtanen, Osmo Antikainen, Heikki Räikkönen, Jouko Yliruusi

Research article
Colorful Drying
AAPS PharmSciTech 11, 46–53 (2010); doi: 10.1208/s12249-009-9351-x
S. Lakio, J. Heinämäki, J. Yliruusi

Short communication
Can encapsulation lengthen the shelf-life of probiotic bacteria in dry products?
International Journal of Food Microbiology, Volume 136, Issue 3, 1 January 2010, Pages 364-367
F. Weinbreck, I. Bodnár, M.L. Marco

List – Publications with MCC spheres, 2009

Research article
Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads
European Journal of Pharmaceutical Sciences, Volume 37, Issue 1, 11 April 2009, Pages 1-10
Chon gFan, Rashmi Pai-Thakur, Wantanee Phuapradit, Lin Zhang, Hung Tian, Waseem Malick, Navnit Shah, M. Serpil Kislalioglu

Short communication
Raman spectroscopic investigation of film thickness
Polymer Testing, Volume 28, Issue 7, October 2009, Pages 770-772
T. Sovány, K. Nikowitz, G. Regdon Jr., P. Kása Jr., K. Pintye-Hódi

Research article
In vivo evaluation of the vaginal distribution and retention of a multi-particulate pellet formulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 73, Issue 2, October 2009, Pages 280-284
Nele Poelvoorde, Hans Verstraelen, Rita Verhelst, Bart Saerens, Ellen De Backer, Guido Lopes dos Santos Santiago, Chris Vervaet, Mario Vaneechoutte, Fabienne De Boeck, Luc Van Borteld, Marleen Temmerman, Jean-Paul Remon

Research article
Modulating pH-independent release from coated pellets: Effect of coating composition on solubilization processes and drug release
European Journal of Pharmaceutics and Biopharmaceutics, Volume 72, Issue 1, May 2009, Pages 111-118
Simon Ensslin, Klaus Peter Moll, Hendrik Metz, Markus Otz, Karsten Mäder

Research article
Dry Particle High-Impact Coating of Biopowders: Coating Strength
Particulate Science and Technology, Volume 27(4), 2009
S. Ötles, O. Lecoq, J. A. Dodds


Research article

Book
Formulation and Analytical Development for Low-Dose Oral Drug Products
John Wiley & Sons , inc. (2009), ISBN 978-0-470-05609-7
Jack Zheng (Editor)

List – Publications with MCC spheres, 2008 and earlier

Research article
Attrition strength of different coated agglomerates
Chemical Engineering Science, Volume 63, Issue 5, March 2008, Pages 1361-1369
B. van Laarhoven, S.C.A. Wiers, S.H. Schaafsma, G.M.H. Meesters

Research article
Direct Drug Loading into Preformed Porous Solid Dosage Units by the Controlled Particle Deposition (CPD), a New Concept for Improved Dissolution Using SCF-Technology
Journal of Pharmaceutical Sciences, Volume 97, Issue 10, October 2008, Pages 4416-4424
Ragna S. Wischumerski, Michael Türk, Martin A. Wahl

Research article
Optimisation of an enteric coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 69, Issue 3, August 2008, Pages 969-976
Nele Poelvoorde, Nathalie Huyghebaert, Chris Vervaet, Jean-Paul Remon

Research article
Dynamic rearrangement of disulfide bridges influences solubility of whey protein coatings
International Dairy Journal, Volume 18, Issue 5, May 2008, Pages 566-573
René Floris, Igor Bodnár, Fanny Weinbreck, Arno C. Alting

Research article
New insight into modified release pellets – Internal structure and drug release mechanism
Journal of Controlled Release, Volume 128, Issue 2, 4 June 2008, Pages 149-156
Simon Ensslin, Klaus Peter Moll, Kurt Paulus, Karsten Mäder

Research article
Development of an enteric-coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 61, Issue 3, October 2005, Pages 134-141
Nathalie Huyghebaert, An Vermeire, Pieter Rottiers, Erik Remaut, Jean Paul Remon

Research article
Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 59, Issue 1, January 2005, Pages 9-15
Nathalie Huyghebaert, An Vermeire, Sabine Neirynck, Lothar Steidler, Eric Remaut, Jean Paul Remon

Research article
Liquid absorption capacity of carriers in the food technology
Powder Technology, Volume 134, Issue 3, 30 September 2003, Pages 201-209
Heidi Lankes, Karl Sommer, Bernd Weinreich

 

Enzyme-cleavable methadone prodrugs Innovations in formulation

Enzyme‑cleavable methadone prodrugs: Functionality, Opportunities, and Summary of US20250361205A1

Introduction to Enzyme‑cleavable methadone prodrugs

Enzyme‑cleavable methadone prodrugs represent a novel class of pharmacological agents designed to provide controlled release of methadone only after specific enzymatic activation. These prodrugs attach an enzyme‑cleavable promoiety to the methadone molecule, rendering it inactive until a target enzyme cleaves the linkage in vivo. This mechanism reduces misuse potential and provides more predictable pharmacokinetics compared to conventional methadone formulations. By depending upon specific enzymatic activity, this prodrug design can improve safety and minimize risks associated with inappropriate administration or overdose, while maintaining therapeutic efficacy for opioid dependence or chronic pain management.

Beyond safety, enzyme‑cleavable methadone prodrugs offer opportunities in advanced drug formulation. They enable precise control over the timing and extent of methadone release based on the activity of endogenous enzymes. As a result, formulators can tailor release rates and reduce systemic peaks that commonly contribute to adverse effects or abuse. These prodrugs also permit formulation with excipients or technologies that further modulate release profiles, including multiparticulate systems or coatings. In addition, controlled enzyme activation provides a strategy to optimize oral delivery, enhance patient compliance, and potentially reduce the burden of supervised dosing programs in opioid maintenance therapy.

Summary of this patent

The patent application US20250361205A1 discloses enzyme‑cleavable methadone prodrugs and corresponding methods of use, focusing on prodrugs that deliver methadone through enzymatically‑controlled release. These prodrugs contain a promoiety linked to methadone that requires cleavage by specific enzymes, such as digestive proteases, before the active opioid is liberated. By requiring enzymatic cleavage followed by intramolecular cyclization to release active methadone, the design significantly lowers the susceptibility to accidental or intentional misuse, including inappropriate routes of administration or chemical tampering.

The disclosed prodrug moieties can include amino acid residues or peptides of up to about 100 amino acids linked via an amide bond to the methadone nitrogen. By selecting promoieties that are substrates for particular enzymes, formulators can adjust release kinetics based on the target enzyme’s activity and distribution. For example, gastrointestinal enzymes like trypsin are contemplated as triggers for prodrug activation. The application also describes including enzyme inhibitors in the pharmaceutical composition to attenuate the rate of enzymatic cleavage when desired. This addition can further control release profiles and reduce unintended rapid activation.

The patent describes general chemical structures of enzyme‑cleavable methadone prodrugs, outlining variations in functional groups and linkers that influence both stability and enzymatic susceptibility. These structures include several formulae (e.g., MD‑(I), MD‑(II), MD‑(III)), each representing different classes of promoieties attached to the methadone core. Notably, upon enzymatic cleavage of the promoiety, a stable cyclic urea or other cyclic group forms, which is pharmaceutically acceptable and of low toxicity. The description also covers pharmaceutically acceptable salts, solvates, and crystalline forms of the prodrugs, enhancing formulation versatility.

A key advantage emphasized in this disclosure is the reduction of excessive plasma methadone levels when the prodrug is administered improperly. Because the prodrug cannot be converted to methadone without specific enzymatic action and cyclization, the risk of overdose is reduced. Furthermore, the document details that trypsin inhibitors or other enzyme modulators may be co‑formulated to regulate the enzymatic activation rate. In addition to the chemical and pharmacokinetic considerations, the application mentions pharmaceutical compositions that include typical excipients, such as fillers, binders, and disintegrants, that support conventional formulation processes for oral delivery.

Use of CELLETS® in This Context

Although CELLETS® (highly spherical microcrystalline cellulose pellets used as starter cores in multiparticulate drug delivery systems) are not explicitly referenced in US20250361205A1, the broader formulation context suggests potential relevance. CELLETS® provide uniform and inert starter cores that support controlled layering of active pharmaceutical ingredients. In multiparticulate systems, CELLETS® improve coating uniformity, flow properties, and controlled release profiles in oral dosage forms. These characteristics make them useful for advanced prodrug formulations where release kinetics and consistency are critical, particularly when precise layering of enzyme‑cleavable prodrug moieties is required. Unlike conventional inert cores, CELLETS® enable predictable performance and facilitate scalable manufacturing for complex oral formulations.

In this patent, some particle sizes of CELLETS® are explicitely named:

Type Particle size distribution
(≥ 85 %)
learn more
CELLETS® 100 100-200 µm
(150/80)
more information
CELLETS® 200 200-355 µm
(80/50)
more information
CELLETS® 350 350-500 µm
(50/35)
more information
CELLETS® 500 500-710 µm
(35/25)
more information
CELLETS® 700 700-1000 µm
(25/18)
more information
CELLETS® 1000 1000-1400 µm
(18/13)
more information

Conclusion and Outlook

In summary, enzyme‑cleavable methadone prodrugs offer a promising advancement in opioid therapy and formulation science, combining controlled enzymatic activation with enhanced safety. The patent US20250361205A1 details chemical constructs and methods that reduce misuse potential and allow sophisticated control of drug release. Given ongoing needs for safer opioid medications, these prodrugs could transform maintenance therapy and pain management by minimizing overdose risks and improving patient compliance. Looking forward, integrating technologies such as multiparticulate delivery systems and optimized excipients (e.g., CELLETS®) will further refine dosing precision and therapeutic outcomes. Future research and clinical evaluation will determine how these designs perform in real‑world settings, including their impact on pharmacokinetics, abuse deterrence, and commercial viability.

Patent Summary

  • Name of Patent: Enzyme-cleavable methadone prodrugs and methods of use thereof
  • Patent Number: US20250361205A1
  • Year of Patent: 2025
  • Patent Holders: Lynn Kirkpatrick
  • Affiliation: Ensysce Biosciences Inc.

Enzyme-cleavable methadone prodrugs Innovations in formulation

UV Imaging of MUPS Tablets Stability, Functionality, and Outcomes

Introduction to UV Imaging of MUPS Tablets

UV imaging of MUPS tablets (multiple unit pellet system) is a growing field in pharmaceutical research. These tablets combine many coated pellets into one compressed unit. After ingestion, the tablet breaks apart and releases the active pharmaceutical ingredient (API). Researchers explored whether multispectral UV imaging could track the degradation of acetylsalicylic acid (ASA) into salicylic acid (SA). The goal was to confirm that this non-destructive method could monitor stability inside these complex formulations.

Scientific Approach to UV Imaging of MUPS Tablets

The study used CELLETS® 700 as neutral microcrystalline cellulose cores. Scientists layered ASA on these cores and coated them with Eudragit RL PO. They then compressed the pellets into MUPS tablets. The tablets were stored at different temperatures and humidity levels for several months.

At each time point, the tablets were examined with multispectral UV reflectance imaging. This technology captured detailed spectral fingerprints across the surface. To interpret the data, the team applied partial least squares regression (PLS). They predicted the concentration of SA as the main degradation product. High-performance liquid chromatography (HPLC) provided reference values for comparison, ensuring accuracy.

Results of UV Imaging of MUPS Tablets

The outcomes showed that UV imaging worked well for tracking degradation inside the tablets. The predictions matched closely with HPLC results, proving the method’s reliability. Moreover, the technique detected even small amounts of salicylic acid despite the tablet’s protective coating.

Importantly, UV imaging did more than quantify. It created spatial maps that revealed where degradation occurred on the tablet surface. These maps gave new insights into stability that destructive tests could not provide. As a result, the method proved fast, precise, and suitable for quality control and stability studies.

Role of CELLETS® 700 in the Research

CELLETS® 700 played a key role in the experiment. These spherical microcrystalline cellulose pellets range from 700 to 1,000 µm. Their smooth, uniform surface made it easy to apply ASA and coatings evenly. In addition, their chemical stability ensured that imaging signals came only from the coating and degradation layers.

Because CELLETS® 700 are robust, they maintained their structure during compression. This consistency improved the reliability of UV imaging results. Thus, the choice of these pellet cores supported both the technical and analytical goals of the study.

Conclusion

UV imaging of MUPS tablets offers a powerful tool for monitoring stability and degradation. By combining multispectral imaging with statistical modeling, researchers gained accurate and non-destructive insights into tablet quality. CELLETS® 700 provided the structural foundation that made the method effective. Consequently, this approach holds promise as a process-analytical technology for pharmaceutical development and quality assurance.

References

UV imaging of multiple unit pellet system (MUPS) tablets: A case study of acetylsalicylic acid stability
European Journal of Pharmaceutics and Biopharmaceutics, Volume 119, October 2017, Pages 447-453
Anna Novikova, Jens M. Carstensen, Thomas Rades, Claudia S. Leopold

Real-time monitoring of multiparticulate coating processes

Real-time monitoring of multiparticulate coating processes at industrial-scale is a critical demand for continuous and batch-wise process technologies. A combination with ultra-high-resolution optical coherence tomography is indeed a brilliant idea. Results were recently published by Wolfgang et al. [1]

Previous challenges in PAT of multiparticulate systems

This study presents a significant advancement in pharmaceutical process analytical technology (PAT) by introducing an industrially viable method for real-time, in-line monitoring of multiparticulate coating processes using ultra-high-resolution optical coherence tomography (UHR-OCT). Optical Coherence Tomography (OCT) is a non-invasive imaging technology that has already shown promise in monitoring pharmaceutical coating processes, particularly for tablets. However, its application in multiparticulate systems—like pellets and mini-tablets—has been limited due to technical challenges such as small particle sizes, thin coatings, and process-induced disturbances.

Multiparticulate dosage forms require coatings as thin as 2.5 microns, necessitating extremely high spatial and temporal resolution in the monitoring equipment. Traditional OCT systems struggled with this due to limitations in sensor stability, acquisition speed, and resolution. Previous attempts to apply OCT in such contexts were mostly proof-of-concept and not scalable to industrial levels. They also failed to monitor enough particles per minute to gather statistically relevant data for real-time quality assurance.

Real-time monitoring of multiparticulate coating processes

In this study, the authors successfully integrated a UHR-OCT system into two industrial fluid bed coaters: the Glatt MultiLab (Glatt GmbH, Binzen/Germany, 2 kg batch size) and Glatt GPCG PRO 30 (30 kg batch size). These coaters function based on the Wurster principle, which enables excellent particle separation and uniform coating application, making them ideal for high-quality coating processes. The novel sensor setup developed by the authors allowed for automated, high-resolution, real-time measurements of coating thicknesses ranging from 2.5 to 20 µm, even for diverse particles as small as 250 µm (CELLETS® 250-355, IPC, Dresden/Germany) up to 1000 µm (CELLETS® 700, IPC, Dresden/Germany) in diameter.

One of the key innovations was the design of a process interface that could withstand the dynamic and harsh environment inside fluid bed coaters, including challenges such as vibration and dust. This setup allowed for consistent data acquisition and evaluation across different batch sizes, proving its scalability and robustness. Reference measurements based on sprayed coating mass closely matched the OCT measurements, especially when particle agglomeration was minimal, further validating the accuracy of the system.

The study also involved image-based photometric analysis, which underscored the effectiveness of UHR-OCT in capturing fine details of the coating layers. The findings suggest that this method can serve as a powerful PAT tool for real-time release testing, quality assurance, and process optimization in industrial pharmaceutical manufacturing. By enabling precise monitoring of extremely thin coatings on small multiparticulates, this technology helps ensure product quality and efficacy while potentially reducing production costs and time.

Conclusion

In conclusion, the authors demonstrate that UHR-OCT is not only capable of meeting the demanding requirements of multiparticulate coating monitoring but also scalable and adaptable to industrial environments. This development marks a significant step toward broader adoption of OCT-based PAT tools in the pharmaceutical industry, particularly for advanced drug delivery systems involving small, coated particles.

References

[1] International Journal of Pharmaceutics (2025), 675, 125546. doi: 10.1016/j.ijpharm.2025.125546.

Abstract

The present invention generally relates to enteric-coated particles containing lactoferrin. More specifically, the present invention provides an enteric-coated particle comprising (or consisting essentially of): a) a core comprising (or consisting essentially of) an inert core-forming material selected from cellulose polymer, sugar, sugar alcohol, starch and carnauba wax; b) a first coating layer substantially covering the core and comprising (or consisting essentially of) b-1) lactoferrin, b-2) a pharmaceutically acceptable binder and optionally b-3) one or more other suitable excipients, such as a plasticizer; and c) a second coating layer substantially covering the first coating layer and comprising (or consisting essentially of) c-1) an enteric coating material, and optionally c-2) one or more suitable excipients, such as a plasticizer and/or an anti-tacking agent. The present invention further provides pharmaceutical compositions and oral dosage forms comprising one or more particles according to the present invention. [1]

Enteric-coated particles with CELLETS® and other starter beads

This formulations is based on starter beads, exemplary such as sugar, wax or microcrystalline cellulose (MCC). For the latter material MCC, specifically such as CELLETS® 100, CELLETS® 200, CELLETS® 350, CELLETS® 500, CELLETS® 700, or CELLETS® 1000 are mentioned. Through coating and layering of CELLETS® with excipients and the active, a modified release is obtained wherein at most 10% of lactoferrin is released from the particle within 120 minutes.

Document information

Document Type and Number: (“enteric-coated particles containing lactoferrin”)
Kind Code: A1

Inventors:

Grilc, Blaš (Ljubljana, SI)
Bjelosevic, Maja (Ljubljana, SI)
Roskar, Robert (Ljubljana, SI)
Osel, Nika (Ljubljana, SI)
Kristl, Albin (Ljubljana, SI)
Gasperlin, Mirjana (Ljubljana, SI)

Disclaimer

Image was generated with Adobe Firefly Image 3.

[1] Enteric-Coated Particles Containing Lactoferrin – UNIVERZA V LJUBLJANI

Revealing the physical restrictions of caecal influx in broilers through the use of solid and soluble markers

Abstract

A promising strategy to support broiler health and performance in a sustainable way is the enhancement of microbial fibre fermentation in broilers. This fermentation mainly occurs in the caeca, but the actual particle size range that allows caecal influx has not yet been described. This study aimed to understand the physical limitations of caecal influx as a function of broiler age by using both solid and soluble markers. In the first trial, the caecal filter mechanism was studied by microscopically visualising the caecal entrance and measuring caecal lobe development and digesta particle size as a function of age (d 8 to 36) for 44 broilers (Ross 308) receiving a conventional wheat-based diet. In two consecutive trials, microcrystalline cellulose beads (100 to 700 μm) and a combination of fluorescent polystyrene beads (5 to 30 μm) and chromium-ethylenediamine tetraacetic acid (Cr-EDTA) were administered to 176 and 189 broilers, respectively, at different ages (d 8 to 36). Results showed that the actual caecal entrance diameter is significantly reduced due to a dense villi network acting as a filter for digesta inflow. This explains the size gap between the average digesta particle size (D50) of the ileum (451 to 322 μm), caeca (5 to 19 μm) and the outer diameter of the caecal entrance (2000 to 4000 μm) on d 8 to 36. In contrast to the caecal D50, cellulose beads of 700 μm already entered the caeca at 8 d of age, even though the general caecal influx of digesta particles larger than 100 μm seemed very limited. The caecal influx of the markers further exhibited large individual variation among birds. A maximum of 13.2% (d 9) and 4.3% (d 29) of the total administered soluble marker (Cr-EDTA) was detected in the caeca, 5 h after bolus administration. Both solid and soluble markers showed a larger concentration in the caeca at a young age compared to older ages (P < 0.01), possibly related to the limited caecal functioning early in life. These findings highlight the importance of carefully selecting the physical properties of fibres to be added as a function of age to further improve caecal fibre fermentation in broilers.

1. Introduction

Broiler production is in need of sustainable and cost-effective solutions to maintain the high performance and health status of broilers without the use of in-feed antibiotics. A promising strategy to improve gut health and performance is enhancing dietary fibre (DF) fermentation. Although DF is mainly known for its adverse effects on broiler performance due to its undigestible and antinutritional characteristics, more recent studies also show the potential beneficial effects of DF on health and performance (Kheravii et al., 2017; Pourazadi et al., 2020; Vermeulen et al., 2017). Even though these effects are still not completely understood, they seem to depend on the particle size and solubility of the DF addition. Coarse insoluble DF inclusions (> 1000 μm) can act as structural components in broiler diets, which can enhance gizzard functionality and retention time in the upper part of the gastrointestinal tract (GIT). As a result, increased nutrient utilisation and performance can be observed (Donadelli et al., 2019; Kheravii et al., 2017, 2018; Lentle et al., 2006, Pourazadi et al., 2020). In addition, DF fractions can be solubilised and subsequently fermented by microbiota in the broiler’s hindgut, resulting in the production of short-chain fatty acids. These short-chain fatty acids can act as an additional energy source for the broiler and can stimulate the growth of beneficial microbiota, as well as control the growth and expression of invasive genes of pathogenic bacteria. Providing more substrate suitable for beneficial fibre-fermenting bacteria by increasing the fermentable DF content in broiler diets can result in an additional decrease of pathogenic bacteria in the GIT by competitive exclusion (Singh & Kim, 2021; Vermeulen et al., 2017).
Most microbial fermentation of DF in poultry occurs in the caecal lobes, which are two blind sacs located at the junction of the ileum and colon. It is hypothesised that the digesta inflow into these lobes is restricted to very small particles, solutes and fluids, although no exact cut-off in particle size has been described (Svihus et al., 2013). The marked restriction of material that enters the caeca was illustrated by Son et al. (2002), who showed that only 18% of the total excreted dry matter and 17% of the total excreted water passed through the caeca. Several studies using digestibility and transit time markers provide an indication of the physical limitations of caecal influx and illustrate the vast difference between the influx of solid and soluble markers. Ferrando et al. (1987) observed that 500 to 2000 μm fibre particles could not enter the caeca in 8- to 10-week-old broilers, but 9% to 26% of the soluble marker chromium-ethylenediamine tetraacetic acid (Cr-EDTA) did enter the caeca in 1- to 3-week-old broilers in a separate experiment by this research group (Vergara et al., 1989). Similarly, Garçon et al. (2023) described a caecal inflow from 30% to 35% of the soluble digesta fraction in 25-day-old broilers based on the use of the soluble marker cobalt (Co)-EDTA. De Vries et al. (2014) further observed a minimal caecal influx of CrO3, linked to the solid phase of the diet, in contrast to the abundant presence of the soluble marker Co-EDTA in the caeca in 4-week-old broilers.
Although it has been hypothesised that only small particles and fluids can enter the caeca, it has also been shown that the addition of both coarse and fine fibre particles can alter caecal microbiota composition. The increase in beneficial fibre-fermenting species and the decrease in pathogenic species in the caeca after the inclusion of fine fibre particles (80 to 300 μm) has been described by Boguslawska-Tryk et al. (2015), De Maesschalck et al. (2019) and Vermeulen et al. (2017). The modification of caecal microbiota by including coarse (fibre) particles (557 to 3000 μm) has also been demonstrated by Pourazadi et al. (2020) and Jacobs et al. (2010). It is still unclear whether these fibre particles as such can truly enter, or that only the solubles originating from the DF fraction end up in the caeca and alter the microbiota composition.
A promising strategy to increase the beneficial effects of DF on broiler health and performance is to enhance the microbial fermentation of DF in the caeca. Due to the observed physical limitations of caecal influx and the lack of a known threshold in particle size for caecal entry, a better understanding of the mechanisms of caecal influx is required. It is hypothesised that the marked restriction of the caecal influx of digesta is mainly due to the extensive network of villi present at the caecal entrance (Svihus et al., 2013). Histological research on the caecal lobes in broilers, layers, geese and quail has shown important differences in microstructures, such as villi, between the different sections (proximal, middle and distal). Well-developed villous structures are abundantly present in the proximal part of the caecal lobes, whereas more fold-like structures can be seen in the middle part and little to no folds are present in the distal part (Chen et al., 2002; Majeed et al., 2009; Pandit et al., 2018; Svihus et al., 2013). Based on this trend of extensive villi development towards the opening of the caecal lobes, a dense network of villous structures can be expected at its entrance. This network could be partly responsible for the filtering mechanism at the caecal entrance by acting as a sieve for the ileal digesta (Clench & Mathias, 1999; Fenna & Boag, 1973; Svihus et al., 2013). In our research group, it was observed that caecal lobe weight and the size of the opening increases with broiler age, which could indicate that the particle size threshold for caecal entry also increases with age (Bautil et al., 2021). Research on the effect of age on the mode of action of this caecal filter mechanism and its histological structure in broilers is still very limited.
As outlined above, the actual size range of particles that can enter the caeca has not yet been described. In addition, multiple studies have already shown that both fine (< 300 μm) and coarse (> 1000 μm) fibre additions can affect the composition and metabolic functioning of the caecal microbiota and the resulting fermentation (Boguslawska-Tryk et al., 2015; De Maesschalck et al., 2019; Jacobs et al., 2010; Pourazadi et al., 2020; Vermeulen et al., 2017). It remains, however, unclear if these fibre additions enter the caeca maintaining their initial particle size, or that they affect the caecal functioning through other mechanisms. Hence, the aim of the current study is to acquire a deeper understanding of the physical limitations of caecal influx. This can enable valuable insights to explore new strategies to further increase DF fermentation in poultry.

2. Materials and methods

2.1. Animal ethics statement

The broiler trials were approved by the Ethical Committee for the experimental use of animals of the KU Leuven under accession number P140/2020.

2.2. Broiler Housing, Diets and Sampling

Three consecutive broiler trials were conducted to study the physical limitations of caecal entrance by means of particle size in broilers. In the first part of this research, the size of the digesta particles present in the caeca was quantified for broilers fed a conventional wheat-based diet (control trial). In the second part, solid and soluble inert markers were administered to broilers in two trials to explore the particle size that allows caecal influx as a function of age.
For all three trials, conventional heating, ventilation and lighting conditions for broiler housing were applied (Aviagen, 2018). The housing temperature was set at 34 °C on d 1, gradually decreased to 21 °C at d 27 and thereafter kept constant at this temperature. The light schedule consisted of 23 h light and 1 h darkness (23:00 to 00:00) from d 1 to d 7, followed by a schedule of 18 h light and 6 h darkness (23:00 to 05:00) until the end of the trial. All broilers were kept in floor pens with fresh wood shavings and received water and feed ad libitum. Inspection of the supply of water and feed, housing conditions, health status of the broilers and mortality was carried out daily. The same basal wheat-based diet was used for the three trials (Table S1). This diet did not contain fibre-degrading enzymes but did include phytase.

2.2.1. Control trial: caecal development and digesta particle size as a function of age

For the first trial, 44 broilers (Ross 308) at one day old were purchased from a commercial hatchery (Belgabroed NV, Merksplas, Belgium) and raised in one floor pen. At d 8, 15 and 36, a total of 18, 12 and 6 broilers, respectively, were sacrificed by electronarcosis followed by decapitation. The chyme and digesta of the gizzard, duodenum-jejunum, ileum (the section between Meckel’s diverticulum and ileocaecal intersect) and caeca were collected by gentle finger stripping of the segments and pooled per 3, 2 and 1 broilers on d 8, 15 and 36, respectively to obtain 6 replicate pools of digesta at each sampling age for further analysis. The caecal lobes and the ileocaecal intersect of each broiler were also collected. Digesta samples and caecal lobes were stored at -20 °C and the intersect at -80 °C until further analysis. The weight and length of the caecal lobes and the circumference of the caecal entrance (using a ruler) were measured during sampling.

2.2.2. Cellulose bead trial (large solid marker)

For the second trial, 176 male broilers (Ross 308) at one day old were purchased from a commercial hatchery (Belgabroed NV, Merksplas, Belgium) and randomly divided over 4 floor pens. Each pen was assigned to one dietary treatment and contained 44 broilers. The dietary treatments consisted of the basal wheat-based diet (Table S1) supplemented with 1% microcrystalline cellulose beads (Cellets®, Ingredientpharm, Pratteln, Switzerland) of one of 4 different particle sizes: 100, 200, 300, and 700 μm. At d 8, 15, 25 and 36, a total of 18, 12, 6 and 6 broilers, respectively, per dietary treatment were sacrificed by electronarcosis followed by decapitation. Digesta was pooled per 3, 2, 1 and 1 broilers on d 8, 15, 25 and 36 respectively to obtain 6 replicate pools of sufficient digesta at each sampling age for further analysis. Digesta collection and measurement on the caecal lobes were executed as described for the control trial (2.2.1).

2.2.3. Fluorescent polystyrene beads (small solid marker) and Cr-EDTA (soluble marker) trial

For the third consecutive trial, a total of 105 male broilers (Ross 308) at one day old were purchased from a commercial hatchery (Belgabroed NV, Merksplas, Belgium) and randomly divided over floor pens. On d 9 and d 29, a marker bolus of 1 mL was administered through oral gavage to 70 and 35 broilers, respectively. The bolus administration started in the morning, resulting in an administration starting time 9 or 4 h after the dark period at d 9 or d 29, respectively. No fasting period was applied beforehand to ensure conventional bowel movements, caecal filling and transit time. The bolus contained the soluble marker Cr-EDTA (954 μL/mL) and three types of solid fluorescent polystyrene microbeads (Spherotech™, Gentaur, Kampenhout, Belgium) with average particle sizes (D50) of 5 μm (1%, wt/vol), 15 μm (0.2%, wt/vol) and 30 μm (1%, wt/vol) with a concentration of respectively 9, 9 and 26 μL/mL in the bolus. On d 9 and d 29, respectively, 14 and 7 broilers per time point were sacrificed by electronarcosis followed by decapitation at 1, 3, 5, 10 and 24 h after the bolus administration to collect 7 replicate digesta pools per time point. At d 9, digesta was pooled per two broilers to obtain a sufficient amount for further analysis. Chyme and digesta of the gizzard, duodenum-jejunum, ileum (the section between Meckel’s diverticulum and ileocaecal intersect) and caeca were collected by gentle finger stripping the segments. The digesta and the emptied parts of the GIT were stored at -20 °C until further analysis.

2.3. Measurements on intestinal and digesta samples of the control trial

2.3.1. Microscopic visualisation of the caecal entrance

The tissue of the caecal entrance was embedded according to an adjusted method of Chen et al. (2002). Sections of the caecal entrance of each sampling age (d 8, 15, 36) were fixed in a 3.0% paraformaldehyde-1.0% glutaraldehyde solution for 16 h, after which they were washed with saline solution (0.9%) and cut into 5-mm tissue slices with a scalpel to obtain minimally 2 slices per caecal entrance. The tissue slices were dehydrated in ethanol series with increasing concentration (70% to 100%), cleared with toluene (99.8%), and then embedded in paraffin. These paraffin blocks were cut into 8-μm thick sections with a Leica RM2255 microtome (Leica Biosystems Nussloch GmbH, Nussloch, Germany). Sections were subsequently stained with hematoxylin (6 min) and eosin (30 s) for histological analysis. Dimensions of the caecal opening were measured using light microscopy (Nikon Eclipse 80i microscope, Nikon Inc., New York, USA) and ImageJ.

2.3.2. Determination of diet, ileal and caecal digesta particle size distribution

The particle size distribution of the diets (starter, grower, finisher) and of the ileal and caecal digesta at each sampled age (d 8, 15, 36) was measured with a Laser Diffraction Particle Size Analyzer LS 13 320 (Beckman Coulter Inc, Indianapolis, IN, USA). This device can measure particle sizes ranging from 0.375 to 2000 μm and assumes that all particles are spherical to generate a volumetric particle size distribution. Diets and ileal digesta were sieved through a 1000-μm mesh prior to this analysis due to technical restrictions (i.e. limit in particle size range) of the device. The volumetric D50 was also calculated for each measurement.

2.4. Detection and quantification of markers in digesta samples

2.4.1. Quantification of cellulose beads (large solid marker)

Ileal and caecal digesta samples of d 8, 15, 25 and 36 of broilers fed the diets enriched with cellulose beads were microscopically screened for the presence of the beads. Prior to bead screening, digesta samples were diluted as follows: 0.2 mL of caecal digesta (50.0 mg) of each replicate pool was diluted in 2.0-mL demineralised water in triplicate. Then, 0.2 mL of these solutions was placed on a microscopy glass to screen for cellulose beads. This microscopic screening was performed in triplicate for each solution to determine the presence of 100, 200 and 300 μm beads (10× magnitude, Nikon Eclipse 80i microscope, Nikon Inc., New York, USA). Due to the large size of the 700 μm beads, their presence was determined by visually screening the diluted digesta samples.

2.4.2. Detection of fluorescent polystyrene beads (small solid marker)

The collected digesta samples were screened for the presence of fluorescent polystyrene beads in collaboration with the Roeffaers Lab (KU Leuven, Belgium). After lyophilisation and grinding of ileal and caecal digesta samples of broilers that received the marker bolus, 50 mg digesta of each sample was suspended in 1 mL demineralised water. 250 μL of this solution was mixed with 250 μL agar and poured into a 9.4 mm × 10.7 mm × 9.3 mm well of an Ibidi μ-Slide 8 well for visualisation with a Leica TCS SP8X (Leica Microsystems GmbH, Germany). Three excitation and emission wavelength combinations were used simultaneously to detect the fluorescent polystyrene beads based on the optimal excitation and emission wavelength ranges of each bead type (wavelengths provided in Supplementary Table S2). Tile scans of the complete wells were made by capturing images of 517μm × 517 μm and a z-section depth of 1.2 μm (405 nm excitation) or a z-section depth of 1.7 μm (590 nm excitation) with a 10x magnification objective lens using Leica Application Suite X software (LAS X, Leica Microsystems GmbH, Germany). Image processing and bead counting was done through LAS X software and ImageJ, after which the number of beads on each image was summed to obtain a total bead count per tile scan and digesta replicate pool. Seven replicate pools of ileal and caecal digesta samples of d 8 and 25 of the control trial (2.1.1) were utilised in this analysis as control samples to validate the described bead detection method.

2.4.3. Quantification of Cr-EDTA (soluble marker)

Ileal and caecal digesta samples of broilers that received the marker bolus were lyophilised, ground, and subjected to an acid closed vessel digestion. Two reference samples of 100 mg Beech BR100 and three negative controls were included in each analysis. Eight milliters HNO3 (69%) was added to digesta samples (100 mg) of each replicate pool of both ages (d 9 and d 29). After a predigestion of 30 min, the samples were digested in a MARS 6 microwave (CEM, Matthews, North Carolina, United States) in closed MARSXpress Teflon tubes for 70 min at 180 °C (including 25 min warm-up and 25 min cool-down time). Next, 42-mL Milli-Q water was added to each digested sample. The samples were further diluted 4-fold with Milli-Q water, after which the solubilised Cr was measured through inductively coupled plasma spectrometry (ICP-MS, Agilent 7700x, Agilent Technologies, Santa Clara, California, United States). This resulted in an ileal and caecal Cr concentration (mg Cr/kg dry digesta) per replicate, which was converted to the total Cr content in the ileum and caeca based on the total digesta dry weight collected per replicate during sampling. The percentage of Cr found in the caeca compared to the total administered Cr in the bolus was also calculated.

2.5. Statistical analysis

Statistical analyses were performed using JMP Pro 16 Software and R Statistical Software (v4.0.5; R Core Team 2021). The normality of all datasets was evaluated through a density plot and quantile-quantile plot. The means of full caecal lobe weight, lobe length and caecal entrance diameter were calculated using sample sizes of 18, 12 and 6 broilers, respectively, at d 8, 15 and 36, due to the limited digesta sample size available from the younger birds. Broilers that showed signs of intestinal disease were excluded from this dataset. Significant differences in the mean full caecal lobe weight, lobe length and D50 of caecal digesta (n = 6) between age groups were identified by performing a one-way ANOVA and significantly different means were further identified using a Tukey’s test. Differences between mean caecal entrance diameter and cellulose bead counts in digesta (n = 6) were identified using a Wilcoxon Rank Sum test due to the non-normality of the data. Significant differences between mean total fluorescent bead counts in ileal and caecal digesta of the treated broilers compared to the control broilers (n = 7) were identified by performing a one-way ANOVA and significantly different means were further identified using a Student’s t-test. Significant differences in mean ileal and caecal Cr concentrations between the measured time points and in ranges of caecal influx ratio of Cr at different broiler ages (n = 7) were identified using the Wilcoxon Rank Sum test. Differences between means were considered significant at P < 0.05 and interpreted as a trend at 0.05 ≤ P ≤ 0.10.

3. Results

3.1. Control trial: caecal development and digesta particle size as a function of age

3.1.1. Development of caecal lobes and entrance as a function of age

The evolution of caecal lobe weight, length and circumference of the caecal entrance measured on fresh caecal lobes are shown in Fig. 1. The average weight of both full caecal lobes increased with age from 1.58 g (± 0.40) on d 8 to 12.18 g (± 5.25) on d 36 (P < 0.001). This corresponded to a relative weight of 0.87 g/100 g (± 0.30) BW on d 8 and 0.46 g/100 g (± 0.20) BW on d 36. The average length of the caecal lobe increased from 7.1 cm (± 0.7) on d 8 to 17.6 cm (± 2) on d 36 (P < 0.001). The average diameter of the caecal entrance measured on fresh samples increased from 0.2 cm (± 0.04) on d 8 to 0.4 cm (± 0.05) on d 36 (P < 0.001). Fig. 2 shows the stained sections of the embedded caecal entrances at d 8, 15 and 36. The visualisation of the caecal entrance showed that the true inner diameter of the entrance is markedly reduced due to additional tissue layers inside this entrance at all studied ages. These tissue layers consist of a submucosa layer with protrusions towards the inside of the caeca, on which a villi layer is attached. The average of the geometric mean diameters of the embedded caecal entrances measured 0.1133 cm (± 0.0224), 0.1943 cm (± 0.0457) and 0.2143 cm (± 0.0679) on d 8, 15 and 36, respectively.
Fig. 1

Fig. 1. Violin plots of the length (A), entrance diameter (B) and full weight (C) of fresh caecal lobes of the control trial measured during sampling at d 8 (n = 18), d 15 (n = 12) and d 36 (n = 6). Dots represent the mean value per age, vertical lines represent the Q1 to Q3 boxplot quantiles. Different letters indicate a significant difference between mean values of age groups (P < 0.05).

Fig. 2

Fig. 2. Microscopic images of 8-μm thick sections of caecal entrance tissue embedded in paraffin and stained with hematoxylin and eosin, from caecal lobes of the control trial collected at d 8 (A, B, C), d 15 (D, E, F) and d 36 (G, H, J). The muscular outer layers are stained in light pink, the inner submucosa and villi network are dark purple.

3.1.2. Ileal and caecal digesta particle size distribution as a function of age

The average diet, ileal and caecal particle size distribution of broilers fed a wheat-based diet as a function of age is shown in Fig. 3. There was a significant reduction in particle size as digesta moved from the ileum to the caeca at all studied ages. The D50 of the ileal digesta on d 8, 15 and 36 was 451 μm (± 49), 322 μm (± 25) and 409 μm (± 24), respectively, in comparison to the diameters of the caecal digesta of 5 μm (± 3), 9 μm (± 2) and 19 μm (± 8) at the same age. The D50 of the caecal digesta on d 8 was smaller than on d 36 (P < 0.001). On d 8 and d 15, 70% of the caecal digesta particles were smaller than 10 μm. On d 36, this upper limit for 70% of the particles increased to 30 μm. However, particles up to 400 μm were also present in caecal digesta of d 8. The geometric mean diameters of the caecal entrance (1133 to 2143 μm) vastly exceeded the caecal digesta D50 (5 to 19 μm) at every studied age.
Fig. 3

Fig. 3. Average volumetric particle size distribution of the diets, ileal and caecal digesta of the control group collected at d 8, 15 and 36 (n = 3 for each diet, n = 6 per age group for digesta), expressed as volume percentage. Orange lines represent the diets, blue lines the ileal digesta and green lines the caecal digesta. Dotted, dashed and solid lines represent the particle size distribution at an age of respectively 8, 15 and 36 d.

3.2. Detection and quantification of markers

3.2.1. Detection and quantification of cellulose beads (large solid marker)

All sizes of cellulose beads were found intact in the feed, along the GIT and in the excreta, demonstrating their inertness and suitability as particle size markers in broilers (Fig. S1). Individual body weight and gut development parameters were also not significantly affected by the inclusion of the cellulose beads. Fig. 4 shows the cellulose bead concentration in the caecal digesta for each screened replicate pool per age and per bead size. All sizes of cellulose beads (100 to 700 μm) were detected in at least one replicate pool at all studied ages (d 8 to 36), although the bead concentration in the caeca markedly varied between the replicate pools. A tendency towards higher bead concentrations at d 8 compared to d 36 could be observed irrespective of bead size, and this age effect was significant for the 100 μm and 300 μm beads (P < 0.001). As the bead count per gram of beads differed for each bead size (Table S2), the bead concentrations in digesta could not be compared directly between the different bead sizes. The ratio of the bead concentration in the caeca over that in the ileum is also shown in Fig. 4 per age group and bead size. This ratio indicates the caecal influx of the beads and ranged from 0.6% to 55.9% over all treatments and ages, showing large variability between biological replicates. The ratio was not affected by bead size or broiler age.
Fig. 4

Fig. 4. Beeswarm plots showing the effect of bead size (A: 100 μm [1739 beads per g feed], B: 200 μm [1089 beads per g feed], C: 300 μm [556 beads per g feed], D: 700 μm [55 beads per g feed]) on bead concentration in caecal digesta of broilers at different ages (d 8, 15, 25 and 36, n = 6 per age group). Points represent the bead count per g digesta of each biological replicate and a horizontal line indicates the average bead count per g digesta per age. Different letters indicate a significant difference in mean bead concentration between age groups (P < 0.05). Above each beeswarm, the ratio of bead concentration in the caeca compared to the ileum is given per bead size and age.

3.2.2. Detection and quantification of fluorescent polystyrene beads (small solid marker)

The total count of fluorescent polystyrene beads of 5 μm in digesta of the treated broilers 1 h after bolus administration only differed from the control broilers for the ileal digesta samples at the youngest age (d 9) (P < 0.001), as shown in Fig. 5. No significant differences in ileal (d 29) and caecal (d 9 and d 29) counts of 5 μm beads between the treated broilers and the control were detected. The low concentrations of the beads in the administered bolus, especially of the 15 μm and 30 μm beads due to their larger particle size, hindered their detection in all types of digesta samples. Strong autofluorescence signals of other digesta particles were observed in both the control and bead-treated ileal and caecal digesta samples, which further complicated the detection of the beads (Fig. S2 and Fig. S3).
Fig. 5

Fig. 5. Boxplots of total counts of 5-μm fluorescent polystyrene beads per tile scan by ImageJ for ileal digesta on d 9 (A), ileal digesta on d 29 (B), caecal digesta on d 9 (C) and caecal digesta on d 29 (D) of broilers 1 h after bolus administration compared to control broilers (n = 7 per age group). Different letters indicate a significant difference in mean bead count between treatments (P < 0.05).

3.2.3. Detection and quantification of Cr-EDTA (soluble marker)

Fig. 6 shows the total Cr content in the ileal and caecal digesta over time at d 9 and d 29 for each replicate pool and the average per age and time point, starting 1 h after bolus administration. The first presence of Cr in the ileum and caeca was already observed 1 h after bolus administration on both d 9 and d 29. The ileal Cr content at this first time point was higher at d 9 compared to d 29 (P = 0.022), but this age effect disappeared at later time points in the ileum. In contrast, the caecal Cr content remained higher at d 9 compared to d 29 at time points 3 h (P = 0.001) and 5 h (P = 0.004). The maximal Cr content was observed 3 h after bolus administration in the ileum at both ages, while a first maximal caecal Cr content was observed at the 5 h time point for both ages. The Cr content in the caeca compared to the total administered Cr in the bolus ranged from 3.5% to 13.2% (d 9) and from 1.7% to 4.3% (d 29) at the 5 h time point, with higher values at a younger age (P = 0.004). Relatively large amounts of Cr were retained in the caeca for up to 24 h at both ages, with a large variation between biological replicate pools. The total Cr content in the ileal and caecal digesta 1 h and 3 h after bolus administration and the calculated caecal influx ratio are shown in Fig. 7. Due to the high variation in both ileal and caecal Cr content, the results are shown per replicate pool. The unexpected mortality of three broilers between the period of bolus administration and sampling resulted in 6, 5 and 6 replicate pools instead of 7 in Fig. 7 for the time points 1 h and 3 h (d 9) and 1 h (d 29), respectively. The ratio of the Cr content in the caeca compared to the ileum at the 1 h time point can indicate the caecal influx of Cr or the flow of Cr from the ileum into the caeca. This ratio varied greatly between replicate pools due to variations in both the ileal and caecal Cr content. The caecal influx ratio tended to increase with age from 0.3% to 4% on d 9 to 0.8% to 75% on d 29 (P = 0.055). One replicate pool on d 29 already had a higher Cr content in the caeca compared to the ileum at the 1 h time point, resulting in a caecal influx ratio above 100% (430%). At the 3 h time point, two replicate pools showed a caecal influx ratio above 100%.
Fig. 6

Fig. 6. Beeswarm plots of the total Cr content in ileal (A: d 9, B: d 29) and caecal (C: d 9, D: d 29) digesta collected at 1, 3, 5, 10 and 24 h after bolus administration at d 9 and d 29 (n = 7 per time point and per age group). Points represent the total Cr content (mg) per biological replicate and a horizontal line indicates the average per time point.

Fig. 7

Fig. 7. Dumbbell plots of the Cr content (mg) in caecal (black dots) and ileal (grey squares) digesta collected 1 and 3 h after bolus administration at d 9 (A, B) and d 29 (C, D) of each biological replicate, corrected for digesta dry weights (n = 5 to 7 per age group). The ratio of the Cr content in the caeca compared to the ileum per biological replicate is given as percentage above each measurement.

4. Discussion

The evolution of the broiler’s caeca and the caecal digesta particle size distribution with age were studied as a first step to reveal the physical restrictions of caecal influx. An overall increase in caecal dimensions with age was observed, such as the enlargement in caecal diameter, lobe length and full lobe weight from d 8 to d 36. This illustrates the rapid development of the caeca with age and can also indicate an increase in caecal influx of digesta and fermentation capacity with age (Svihus et al., 2013). The relative full caecal lobe weights and dimensions measured in this study correspond to previous findings in literature when broilers were offered a wheat-based diet (Bautil et al., 2021). The observed increase in caecal weights and dimensions could also be expected based on other studies that recorded caecal development with age in broilers and other young poultry species (AbuAli et al., 2019; Martínez et al., 2021). The sections of the embedded caecal entrances displayed a similar increase in diameter with age, but more importantly, showed that the actual inner diameter of the caecal entrance, relevant for digesta influx, is markedly reduced due to a network of submucosa protrusions and villi. Additional mucus layers can also be expected to be part of this network but were probably lost during the embedding procedure. The visualisation of this network supports the hypothesis that the numerous villi at the caecal entrance act as a filter for incoming digesta particles, as described by Clench & Mathias (1999), Fenna & Boag (1973) and Svihus et al. (2013). This filtering effect was further confirmed by the large shift in D50 from the ileal digesta (409 to 451 μm) to the caecal digesta (5 to 19 μm). The lack of difference between the diet and ileal digesta particle size is mainly due to the required pre-sieving step before laser diffraction analysis. The presence of the villous network at the caecal entrance also explains the large size gap between the measured outer diameter of the caecal entrance (0.2 to 0.4 cm) and the actual D50 of the digesta inside the caeca at all studied ages. The villous network already seemed to be developed in the first week after hatch, but its firmness could however greatly vary with age. It appeared to be more brittle and was harder to visualise in detail at d 8 compared to d 15 and d 36, which can indicate a decreased filtering capacity of the villous network at a younger age. However, the smaller size of the caecal entrance tissue on d 8 compared to d 15 and d 36 could also have increased the difficulty of the visualisation procedure in general. Nonetheless, it is clear that this villous network at the caecal entrance restricts digesta inflow at all studied ages.
Based on the increase in the caecal physiological parameters and the caecal digesta D50 with age, the size of digesta particles that can pass through the caecal filter can also be expected to increase with age. The actual particle size range that allows caecal influx as a function of age was assessed by means of solid and soluble markers in two consecutive broiler trials. The microcrystalline cellulose beads that were used as the large solid marker in this study seemed to be a suitable marker in the broiler’s GIT due to their inertness along the GIT and the absence of an effect on individual body weights and gut development parameters. As previously confirmed in other studies, the soluble marker Cr-EDTA also seemed to be a suitable marker due to its inertness and accurate detection in the digesta (Iji, 2007; Vergara et al., 1989). The first appearance of Cr in the ileum and the caeca in this study was already detected within 1 h after bolus administration. This fast transit of liquid markers to the small intestine corresponds to the report regarding early marker appearance in broilers and quail by Fenna & Boag (1973) and Vergara et al. (1989). The direct administration of the bolus into the crop through the oral gavage technique used in the current study may have additionally accelerated the passage of the markers to the other GIT parts compared to marker intake through regular feeding. The major fraction of Cr was found after 3 and 5 h respectively in the ileum and caeca, corresponding to the expected digesta transit times in these GIT parts (Svihus & Itani, 2019). However, at these later time points, which correspond to the expected time for digesta to reach the caeca, the caecal Cr content already exceeded the ileal Cr content in multiple broilers at d 9, indicating an accumulation of Cr in the caeca and an evacuation of ileal content. The frequency of caecal emptying in broilers is estimated to be every 2 to 8 h based on previous own research (data not shown). Based on these findings, the data from the 1 h time point seemed the most reliable in estimating the flow of markers from the ileum to the caeca, with a minimal effect of caecal accumulation or retention of the markers at d 9. The same time point was used at d 29 to allow a correct comparison between both ages. The caecal influx ratios at the 3 h time point are also shown in Fig. 7, but may already be affected by caecal emptying and accumulation that are still poorly understood. To study caecal marker retention, all time points were taken into account (Fig. 6). Following this reasoning, the detection of the fluorescent polystyrene beads was also performed on the digesta collected 1 h after bolus administration for the estimation of their caecal influx. These fluorescent polystyrene beads were used as small solid markers but seemed less suitable for this study, as only the 5 μm beads were detected in the ileal digesta on d 9 and no beads were detected in the caecal digesta. This mainly seems due to the low administered concentration of the beads (9 to 26 vol % of bead solutions in the bolus), regarding the limited amount of caecal influx of small particles and fluids measured in this paper and previous studies (Garçon et al., 2023; Vergara et al., 1989). In addition, the beads were difficult to detect in the digesta matrix due to their similar size to digesta particles and the interference of the autofluorescence of feed and digesta compared to the relatively low administered bead concentrations. Using higher bead concentrations in the oral bolus and fluorescent coatings that do not overlap with the autofluorescent signal of feed and digesta could improve their suitability as a marker for studies on the broiler’s caeca. Preliminary screening of the samples obtained at later time points than 1 h did not show a better detection of fluorescent beads and were hence not analysed for this marker type.
An overall low caecal influx ratio was observed for both the solid and soluble markers, although this ratio varied between replicate pools. The average caecal influx ratio of the cellulose beads was only 5%, with no significant effect of age or bead size. Despite this low influx, the presence of cellulose beads with particle sizes up to 700 μm in the broiler’s caeca is remarkable, given that only 1% to 15% of the caecal digesta particles of the unsupplemented broilers were larger than 100 μm, and no particles larger than 500 μm were detected. The cellulose beads, however, differ from other digesta particles and from the native cellulose already present in the feed due to their dense microcrystalline structure, spherical shape and smooth surface. This might have facilitated their caecal entry, for example, by pushing through the villous network instead of being withheld as expected for light, non-spherical digesta particles such as wheat bran. The wide range of the caecal influx ratio of the cellulose beads (2% to 56%) over the different replicate pools shows that a high caecal marker concentration of these beads could also be achieved. A similar broad caecal influx range with a high maximum was observed for the soluble marker (0.3% to 75%) 1 h after bolus administration. It is important to note that the reported influx ratios of the cellulose beads, administered through continuous feeding, can be an overestimation if the potential accumulation of markers in the caeca over time is considered (Svihus et al., 2013; Vergara et al., 1989). On the other hand, the caecal influx ratios of the soluble marker can be an underestimation as these were calculated based on marker contents measured 1 h after marker administration. Although using this 1 h data minimizes the effect of caecal emptying and accumulation, later time points are considered more biologically relevant regarding caecal transit time (Svihus & Itani, 2019). These later time points were taken into account when studying caecal retention of the markers, but were not suitable for the calculation of the caecal influx ratio as outlined above. Aside from the infrequent caecal emptying and the possible accumulation of material in the caeca, the inflow of material into the caeca is assumed to be non-continuous and can additionally complicate the measurement and interpretation of caecal influx. A vastly higher caecal influx ratio of the soluble marker compared to the solid marker could have been expected based on the reports by De Vries et al. (2014), Svihus et al. (2013) and Vergara et al. (1989), but was not observed in this study. The absence of this difference may be caused by a greater accumulation of the cellulose beads in the caeca due to their larger size which may facilitate their retention in the caeca once they have entered, and their administration through continuous feeding instead of through a single bolus as used for the soluble marker. Aside from the caecal influx ratio, the maximal Cr content found in the caeca compared to the total amount of administered Cr can indicate the extent to which the soluble digesta fraction can enter the caeca, which ranged from 1.7% to 13.2% in this study, 5 h after bolus administration. Although these values align with the few other studies that quantified caecal influx in broilers, the possible accumulation and infrequent filling and emptying of the caeca should be taken into account for a correct interpretation. It is described that caecal digesta dry matter accounts for 18% of the total excreted dry matter in broilers and that 9% to 35% of the orally administered soluble marker Co-EDTA was found in the caeca, depending on broiler age (Garçon et al., 2023; Son et al., 2002; Vergara et al., 1989). So, despite the non-continuous caecal inflow and outflow dynamics complicating the interpretation of the obtained marker data, this paper confirms that even the caecal influx of the liquid fraction seems very limited. Together with the results on caecal digesta particle size distribution, the current results suggest that a particle size of less than 100 μm is required to achieve maximal caecal access. Although larger particles have also been demonstrated to affect caecal fermentation and microbiota (Boguslawska-Tryk et al., 2015; De Maesschalck et al., 2019; Pourazadi et al., 2020; Vermeulen et al., 2017), these results indicate that they will only enter the caeca in very limited quantities. Hence, despite the use of different marker types and time points in this study, the exact quantification of the fraction of ileal digesta particles that can actually pass the caecal filter to enter the caeca is still hindered by the complex caecal filling and emptying mechanisms and the important role of broiler age. Aside from particle size, other physicochemical characteristics such as solubility, viscosity and molecular weight are also expected to affect the caecal entrance of digesta (Svihus et al., 2013). However, this study did highlight the importance of particle size for caecal influx and provides an indication of the particle size range allowing this caecal influx, within the studied size ranges of the used solid (100 to 700 μm) and soluble markers. These new insights can be of use to further improve the maximal fibre fermentation capacity in the caeca.
In addition to particle size, broiler age also seemed to be an important factor when studying the physical aspects of digesta influx into the caeca. The caecal concentration of 100-μm and 300-μm beads, the total caecal Cr content at time points 3 and 5 h and the maximal percentage of Cr in the caeca compared to the total administered Cr were all higher at a younger age (d 8 to 9) compared to an older age (d 29 to 36). This contradicts the observed increase in caecal dimensions and caecal digesta D50 with age, as well as the increase in the caecal influx of Cr with age as observed by Vergara et al. (1989). The ileal and caecal Cr contents as a function of time (Fig. 6) can indicate a two-sided effect of age on the transit time and retention time of this marker in the GIT. Firstly, the higher ileal Cr content at d 9 compared to d 29 1 h after bolus administration may imply that the precaecal transit time of this marker is shorter at d 9 compared to d 29. Secondly, the increased caecal Cr concentrations at a younger age can be due to the faster passage of liquid digesta material at a younger age as confirmed for the ileal data above, which was also seen by Vergara et al. (1989) for the total tract transit time of Cr-EDTA. However, these authors assigned this age effect to the increase of caecal influx with age, while the current study shows that the passage is already faster in the GIT parts prior to the caeca. Similar to the liquid Cr marker, the results of the cellulose beads show a tendency towards a higher caecal marker concentration at a young age compared to an older age. These higher caecal marker concentrations at a younger age compared to an older age could also be the result of a greater caecal retention of the marker in younger birds. Other studies have shown that digesta can remain in the caeca for longer than 12 or 24 h, leading to increased retention times of certain markers (Garçon et al., 2023; Hinton et al., 2000; Vergara et al., 1989; Warriss et al., 2004). This aligns with the high caecal Cr concentrations observed 24 h after bolus administration. In addition, a longer transit time of the cellulose beads in the GIT at a young age compared to an older age was observed in an extra transit time experiment (data not shown), which may also be attributed to greater caecal retention of this relatively large solid marker. This means that the increased marker concentrations at a young age compared to an older age can reflect their accumulation in the caeca and may indicate a more restricted caecal outflow early in life rather than a more restricted inflow at an older age. This more restricted outflow may result from less contractile activity of the caeca lobes in young birds, which can be related to the previously reported limited functioning of the caeca at a very young age. For example, Svihus et al. (2013) expect that the full fermentation capacity of the caeca is not reached before d 28, which is supported by observations of increased levels of fermentation products formed in the caeca with increasing broiler age (Fischer, 2003; Lee et al., 2017). The increase in fibre fermentation capacity with broiler age is also reported by Bautil et al. (2019), where increased solubilisation and fermentation of arabinoxylan was measured in broilers at 21 d compared to 10 and 5 d. In addition, the bacterial density in the caeca has been observed to increase rapidly from hatch until 7 d, after which the density remains the same up to 30 d (Apajalahti et al., 2004). Similarly, the caecal microbial composition was observed to vary significantly in the first weeks of life (d 1 to d 10) but stabilised from 11 days on (Van Der Wielen et al., 2002). So, the seemingly longer retention of substrates in the caeca of younger birds is possibly a physiological adaptation to the underdeveloped caecal fermentation capacity early in life. Despite the higher Cr content in the caeca at a younger age compared to an older age at time points 3 and 5 h, the caecal influx ratio of Cr calculated 1 h after bolus administration did increase with age from 0.3% to 4% on d 9 to 0.8% to 75% on d 29. This indicates a higher influx of the liquid fraction from the ileum into the caeca at an older age, if caecal accumulation of the marker can be neglected at the 1 h time point. This age effect correspond to the trend observed by Vergara et al. (1989) using the same marker. The caecal influx ratio of the cellulose beads was not affected by age, possibly due to the large biological variation, caecal accumulation of the beads over time or the different physiochemical characteristics of the beads compared to digesta particles as described above. In conclusion, the results indicate that caecal influx of the soluble fraction can increase with age, whereas the accumulation of both the solid and soluble fraction in the caeca seems greater at a young age (d 8 or 9) compared to an older age (d 29 or 36). This accumulation effect might be attributed to the underdeveloped caecal fermentation capacity very early in life. The addition of more accessible fibre adapted to the age-specific caecal fermentation capacity, especially at very young ages, might further improve the nutritious value of broiler feeds as the increased caecal retention time of substrates at this young age provides a longer period for potential microbial fermentation and thus enables a potentially beneficial evolution of the caecal microbiome.
The wide ranges of the caecal content and the caecal influx of both the solid and soluble markers demonstrate the high biological variation that seems to be inherent to studying the caecal influx mechanism in broilers. A possible cause is the complex caecal filling and emptying mechanism, which is still not fully understood. As the caeca are expected to fill and empty in cycles, it is possible that the asynchronisation of these cycles between broilers contributed to the biological variation measured during these types of marker studies despite the synchronised light regimes that were applied for all broilers in the current study (Clench & Mathias, 1999; Fenna & Boag, 1973). As the main objective of this research was to study the caecal influx mechanisms, no fasting was applied prior to the marker administration in the current trials, as this may introduce a caecal filling and emptying behaviour that is atypical of the normal circumstances in which broilers are commercially raised. However, fasting the broilers before marker administration may contribute to the synchronisation of the marker movements along the GIT. This is common practice when using (fluorescent) markers in animals and would also decrease the issue caused by digesta autofluorescence, improving the detection of the fluorescence polystyrene beads (Li et al., 2018; van der Sluis et al., 2009). Another strategy to increase the synchrony in feeding patterns and, thus, caecal cycles between broilers is the use of a restricted feeding regime instead of continuous feeding or the adjustment of the sampling time points to the light regime. Both fasting and restricted feeding can provoke important changes in bowel motility, which is believed to also affect caecal filling, emptying and transit time, and were therefore not applied in the current study (Son et al., 2002).

5. Conclusion

This study showed that the caecal dimensions and digesta D50 increase with broiler age, suggesting that the digesta particle size allowing caecal influx also increases with age. A dense villous network at the entrance of the caeca restricts the inflow of digesta coming from the ileum, which explains the strong decrease in D50 of caecal digesta compared to ileal digesta. The effect of broiler age on the caecal filtering mechanism could be seen in the increased caecal diameter and digesta D50 with age on the one hand, but also in the increased caecal retention of markers at a young age compared to an older age on the other hand. The studied caecal digesta particle size distribution and influx of solid and soluble markers suggest that the caecal influx of particles larger than 100 μm is very limited. The content of the soluble marker Cr-EDTA in the caeca was maximally 13.2% of the initial orally administered dose in this study, illustrating the strong restriction of caecal influx for both solubles and solids. The caecal concentration of all three marker types showed considerable biological variation, which can be due to asynchronised caecal cycles between broilers. The study of caecal influx of markers was further complicated by the infrequent caecal filling and emptying dynamics which are still not fully understood, and by the possible accumulation of the used markers in the caeca. The results of this study highlight the physical limitations of caecal influx dictated by initial particle size and broiler age. Hence, carefully selecting the physical properties of fermentable fibre in function of age might aid in further improving caecal fibre fermentation in broilers.
Paulien Vanderghinste: Writing – original draft, Visualization, Validation, Methodology, Investigation, Formal analysis, Conceptualization. An Bautil: Writing – review & editing, Supervision, Methodology, Conceptualization. Michael R Bedford: Writing – review & editing, Conceptualization. Gemma Gonález-Ortiz: Writing – review & editing, Conceptualization. Chris Lamberigts: Methodology, Investigation. Imran Aslam: Resources, Methodology, Investigation. Maarten Roeffaers: Resources, Methodology. Christophe M Courtin: Writing – review & editing, Supervision, Resources, Conceptualization

Authors

Paulien Vanderghinste, An Bautil, Michael R. Bedford, Gemma González-Ortiz, Chris Lamberigts, Imran Aslam, Maarten Roeffaers, Christophe M. Courtin

Declaration of Competing Interest

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, and there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the content of this paper.

Acknowledgements

Colleagues of the Laboratory of Food Chemistry and Biochemistry, the Nutrition & Animal Microbiota EcoSystems Laboratory and the Laboratory of Livestock Physiology are thanked for their helping hands during the broiler trials. Marie Huyskens is thanked for performing the ICP-MS measurements. Quinten Wouters is thanked for assistance with the Leica TCS SP8X microscope. Paulien Vanderghinste acknowledges the Research Foundation Flanders for a position as PhD fellow (SB3423N).

Appendix A. Supplementary data

Original source: Animal Nutrition, Available online 16 January 2025, https://doi.org/10.1016/j.aninu.2024.12.004
The following is the Supplementary data to this article: Download: Download Word document (8MB)

References

Titelbild Brezovar-2023

Abstract

The focus of the current work is to study and demonstrate the impact of the design, the scale, and settings of fluid-bed coating equipment on the differences in pellet coating thickness, which in case of prolonged-release pellets dictates the drug release. In the first set of coating experiments, the pellet cores were coated with the Tartrazine dye with the aim of estimating the coating equipment performance in terms of coating thickness distribution, assessed through color hue. In the second set, drug-layered pellets were film-coated with prolonged-release coating and dissolution profile tests were performed to estimate the thickness and uniformity of the coating thickness among differently sized pellets. In both study parts, film coating was performed at the laboratory and the pilot scale and essentially two types of distribution plate and different height adjustments of the draft tube were compared. The dye coating study proved to be extremely useful, as the results enable process correction and the optimal use of the process equipment in combination with the appropriate process parameters. Preferential film coating of larger drug-containing pellets was confirmed on the laboratory scale, while on the pilot scale, it was possible to achieve preferential coating of smaller pellets using rational alternatives of settings, which is desirable in terms of particle size-independent drug release profile of such prolonged-release dosage forms. […]

Materials

In the first part of the study, neutral MCC pellets (CELLETS 700, IPC Process Center GmbH, Germany) were coated with water solution composed of 8% w/w HPMC 6 mPas (Shin-Etsu Chemical, Japan), 1% w/w Macrogol 6000 (Clariant Produkte GmbH, Glendorf site, Germany), 1% w/w coloring agent Tartrazine (Sigma-Aldrich, USA), and purified water (90%, w/w).

In the second part of coating experiments, API-coated pellets containing Diclofenac sodium were coated with water-based sustained release coating dispersion containing Eudragit RS 30D (9.6% w/w), Eudragit RL 30 D (19.2% w/w) (Evonic Nutrition Care GmbH, Germany), 1.7% w/w triethyl citrate (Vertellus LLC, USA), and 10.4% w/w talc.

Methods

Pellet Film-Coating Experiments with Tartrazin

Coating experiments using Tartrazine dye were performed on two laboratory-sized fluid-bed coaters (GPCG1, Glatt GmbH, Germany and BX FBD10, Brinox d.o.o., Slovenia) and on one pilot-sized (BX FBD30, Brinox d.o.o., Slovenia) fluid-bed coater. In case of both laboratory coaters, the type of distribution plate and the gap between the plate and the draft tube were varied. The pilot-scale setup with three swirl generators and draft tubes was used, while only the size of the gap was varied during coating experiments (Table I). All other process parameters were comparable within each coating process scale. […]

Size distributions of uncoated CELLETS® 700 used in Tartrazine coating experiments and of drug-layered pellets used in PR coating experiments

Size distributions of uncoated CELLETS® 700 used in Tartrazine coating experiments and of drug-layered pellets used in PR coating experiments

Conclusion

Considering the results of the coating process evaluation with the dye-coated pellet approach, based on previous research, it can be said that the obtained positive slopes of size preferential coating in the laboratory-scale CW process chamber are within the expected performance of this type of coater design. The values of the slope of the size preferential coating were always lower in the case of the SW distribution plate in comparison with the CW design of the distribution plate. However, within the laboratory-scale coater designs, different performances of swirl generator equipped flat and funnel-shaped distribution plates were identified, the latter exhibiting the least size dependent preferential coating performance. This was attributed to a less expressed dead zone effect enabling mixing and elimination of any segregation in the pellet bed region of the coater. On the pilot film-coating scale, coater equipped with flat SW distribution plates exhibited negative size preferential coating slope, meaning that smaller pellets obtained more coating than larger ones, which is unprecedented result. Moreover, the extent of the negative size preferential coating slope depended on the dynamics of the pressure drop fluctuations. This finding was effectively translated to the prolonged-release coating application, where the right extent of the negative size preferential coating ensures pellet size-independent drug release profiles, thus improving robustness of such multiple unit prolonged-release formulation. By lowering the air flow rate and using bimodal size distribution, rich in smaller drug-layered pellets, led to rather surprising results, where performance of prolonged drug release-coated pellets did not resemble size preferential coating results from the dye coating study part.

These results confirm the fact that we must have a good knowledge of the coater performance characteristics in combination with the process variables and even formulation properties, if we want to produce coated multiple-unit solid pharmaceutical products of the highest quality.

Disclaimer

Excerpt from: AAPS PharmSciTech, 24, 93 (2023), https://doi.org/10.1208/s12249-023-02540-9. by T. Brezovar, G. Hudovornik, M. Perpar, M. Luštrik, and R. Dreu.
Modelling the disintegration of pharmaceutical tablets